Abnormalities of gait and mobility

R18_ABNORMALITI_GAIT_MOBIL

gait apraxia: Impaired ambulation not attributed to sensory impairment or motor weakness. frontal lobe disorders; basal ganglia diseases (e.g., parkinsonian disorders); dementia, multi-infarct; alzheimer disease; and other conditions may be associated with gait apraxia.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — R26 Cause of death: ICD-10 — R26 2 out of 7 registries used, show all original rules.	4591
4. Check minimum number of events None	4591
5. Include endpoints None	4591
6. Filter based on genotype QC (FinnGen only)	4591

Control definitions (FinnGen only)

Control exclude: R18_SYMPTOMS_SIGNS_INVOLVI_NERVOUS_MUSCULOS_SYSTEMS

Extra metadata

Level in the ICD hierarchy: 3
Special: GAITCHANGE
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: R25-R29
Name in latin: Abnormitates incessus et mobilitatis

NAME	R18_ABNORMALITI_GAIT_MOBIL
CONTROL_EXCLUDE	R18_SYMPTOMS_SIGNS_INVOLVI_NERVOUS_MUSCULOS_SYSTEMS
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	R26
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	R26
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Abnormalities of gait and mobility based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	4591	2122	2469
Unadjusted period prevalence (%)	0.92	0.72	1.09
Median age at first event (years)	68.14	65.26	70.63

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
4029: Matched controls
40290

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

87.0

323.0

583

R26.2

ICD-10 Finland

Difficulty in walking, not elsewhere classified

834.4

323.0

1229

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

8.7

323.0

1018

1503

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

1962.9

323.0

2623

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

5.4

303.7

1049

2453

R26.0

ICD-10 Finland

Ataxic gait

416.6

275.9

274

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

7.7

223.0

554

813

L28

ICPC

Limited function/disability (L)

3.5

200.0

1130

4006

AA1AD

NOMESCO Finland

CT of head and brain

2.9

181.6

1459

6567

G91.2

ICD-10 Finland

Normal-pressure hydrocephalus

18.2

178.5

284

167

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

4.5

177.9

716

1863

M48.0

ICD-10 Finland

Spinal stenosis

3.6

171.9

916

3049

M79.6

ICD-10 Finland

Pain in limb

2.6

160.8

1737

9162

R4110

NOMESCO Finland

Physiotherapy

2.7

157.1

1489

7263

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

4.7

155.7

587

1417

A28

ICPC

Limited function/disability NOS

3.0

150.7

1036

4112

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

6.8

135.7

363

578

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

13.9

131.9

233

177

R42

ICD-10 Finland

Dizziness and giddiness

2.6

131.1

1216

5731

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

6.0

128.8

379

683

N03AX16

ATC

pregabalin; oral

2.6

128.8

1202

5671

B01AC04

ATC

clopidogrel; oral

2.7

126.7

1040

4548

PEF23

NOMESCO Finland

Thrombendarterectomy of femoral artery

9.3

117.7

255

291

PEN23

NOMESCO Finland

Plastic repair of femoral artery

15.5

115.7

195

132

TAB00

NOMESCO Finland

Lumbar puncture

6.2

114.0

328

572

R53

ICD-10 Finland

Malaise and fatigue

2.5

111.0

1065

5029

L17

ICPC

Foot/toe symptom/complaint

2.3

109.3

1276

6663

AAF05

NOMESCO Finland

Ventriculoperitoneal shunt

13.1

103.0

186

148

N03AX12

ATC

gabapentin; oral

2.8

102.2

779

3201

R26

ICD-10 Finland

Abnormalities of gait and mobility

61.2

101.6

119

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

3.7

93.2

443

1294

PE1AT

NOMESCO Finland

Femoral artery PTA

10.0

92.1

190

198

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

5.0

90.0

309

661

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.0

89.5

2009

13548

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

14.0

86.2

151

112

PD3YT

NOMESCO Finland

Pelvic artery PTA with stent

10.3

84.9

172

173

XF400

NOMESCO Finland

ECG with 12 standard connections

2.3

83.3

922

4582

R27.0

ICD-10 Finland

Ataxia, unspecified

129.9

83.3

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.0

82.6

1383

8243

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.6

80.6

693

3016

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

7.8

79.7

191

256

N02BE01

ATC

paracetamol; systemic, rectal

2.2

78.7

3447

29229

N06AX21

ATC

duloxetine; oral

3.0

77.5

494

1786

M54.5

ICD-10 Finland

Low back pain

2.0

76.5

1301

7751

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.3

74.6

837

4160

WX408

NOMESCO Finland

General anesthesy, balanced

2.0

73.6

1243

7358

N02AX02

ATC

tramadol; systemic, rectal

1.8

72.4

1789

12148

I702, R262

ICD-10 Finland

+∞

71.0

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

3.5

70.2

362

1120

A04

ICPC

Weakness/tiredness general

2.4

66.4

649

2996

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.7

65.8

505

2038

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.6

65.7

519

2133

R25.1

ICD-10 Finland

Tremor, unspecified

7.4

64.1

158

221

N06AX11

ATC

mirtazapine; oral

1.9

63.9

1252

7748

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

10.5

63.0

126

124

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.1

61.9

825

4384

TPH04

NOMESCO Finland

Cathetrisation of vein

2.0

61.4

965

5485

N17

ICPC

Vertigo/dizziness

2.4

60.3

564

2536

L03

ICPC

Low back symptom/complaint

2.0

59.6

970

5576

PD4CM

NOMESCO Finland

Extensive MRI examination of abdominal aorta and vasculature of lower extremities with 3 Tesla magnet

23.4

58.9

A02BC02

ATC

pantoprazole; systemic

1.7

58.5

2535

19970

N05AH04

ATC

quetiapine; oral

2.2

57.2

633

3082

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

2.3

56.5

606

2909

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.6

56.2

455

1887

N29

ICPC

Neurological sympt/complt other

6.3

56.2

155

254

XA800

NOMESCO Finland

Neuropsychological investigation

4.1

55.8

231

591

N28

ICPC

Limited function/disability (N)

6.8

55.6

145

220

XP60W

NOMESCO Finland

28.3

54.9

R4120

NOMESCO Finland

Occupational therapy

3.0

54.6

349

1252

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

3.1

53.8

320

1094

WX110

NOMESCO Finland

Local anesthesy

1.7

52.9

2549

20384

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

3.0

52.6

323

1127

R20.2

ICD-10 Finland

Paraesthesia of skin

3.2

52.6

290

939

N06AX16

ATC

venlafaxine; oral

2.4

52.2

499

2254

N06AB04

ATC

citalopram; systemic

2.0

52.0

838

4764

M54.4

ICD-10 Finland

Lumbago with sciatica

2.1

52.0

652

3347

I10

ICD-10 Finland

Essential (primary) hypertension

1.7

51.5

2486

19809

PEN25

NOMESCO Finland

Plastic repair of superficial femoral artery

17.9

51.5

L29

ICPC

Musculoskeletal sympt/complt other

2.7

50.4

380

1509

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.8

50.4

347

1305

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.5

50.2

419

1763

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.6

50.0

393

1597

C07AB07

ATC

bisoprolol; oral

1.6

49.0

2032

15437

R06.0

ICD-10 Finland

Dyspnoea

1.8

48.8

1070

6751

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.7

48.8

1205

7896

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.7

48.5

1721

12520

TKC20

NOMESCO Finland

Catheterisation of bladder

2.5

47.5

406

1728

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.4

46.6

440

1972

N99

ICPC

Neurological disease other

8.8

46.5

102

119

N03AX09

ATC

lamotrigine; oral

3.9

46.5

202

540

ZXA00

NOMESCO Finland

Right side

1.7

46.2

1191

7877

G20

ICD-10 Finland

Parkinson disease

3.7

45.7

208

578

C10AA05

ATC

atorvastatin; oral

1.6

45.7

1650

11998

N03AG01

ATC

valproic acid; systemic, rectal

3.1

45.6

273

936

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.7

45.0

1199

7997

PEN24

NOMESCO Finland

Plastic repair of deep femoral artery

15.3

45.0

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.9

45.0

749

4282

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.7

44.6

1086

7049

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

3.2

44.5

244

785

PE1BT

NOMESCO Finland

Femoral artery extensive PTA

8.8

44.3

113

PE1YT

NOMESCO Finland

Femoral or popliteal artery PTA with stent

7.2

44.1

109

154

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.6

44.0

351

1436

SPAT1216

SPAT

Assessment of functional ability

1.9

43.4

714

4059

N05CF01

ATC

zopiclone; oral

1.7

43.1

1280

8784

N05BA01

ATC

diazepam; systemic, rectal

2.1

43.0

572

2994

R60.0

ICD-10 Finland

Localized oedema

2.1

42.8

516

2589

C03CA01

ATC

furosemide; systemic

1.7

42.6

1343

9361

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.7

42.6

1297

8955

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.7

41.8

297

1135

R51.80

ICD-10 Finland

Headache

2.1

41.6

532

2734

A01

ICPC

Pain general/multiple sites

2.5

41.4

347

1459

R56.8

ICD-10 Finland

Other and unspecified convulsions

3.1

41.3

241

809

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.1

40.8

518

2652

NA7BG

NOMESCO Finland

Spine and spinal cord MRI examination with high intensity magnet

13.3

40.8

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.1

40.8

524

2697

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.9

40.6

259

925

PEF24

NOMESCO Finland

Thrombendarterectomy of deep femoral artery

12.1

40.3

N03AE01

ATC

clonazepam; systemic

2.9

40.0

262

952

ZXA05

NOMESCO Finland

Left side

1.7

40.0

1099

7346

J01DB01

ATC

cefalexin; oral

1.6

40.0

3086

26789

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

2.4

39.2

350

1518

WX402

NOMESCO Finland

General anaesthesia

1.9

39.1

650

3696

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.8

39.0

718

4230

TPH07

NOMESCO Finland

Cathetrisation of artery

2.1

39.0

505

2606

N30.0

ICD-10 Finland

Acute cystitis

2.0

39.0

550

2936

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

5.1

38.7

125

249

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.0

38.6

592

3265

A29

ICPC

General symptom/complaint other

2.1

38.4

502

2598

G04BD12

ATC

mirabegron; oral

2.1

38.3

489

2507

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

3.2

38.1

210

679

M54.1

ICD-10 Finland

Radiculopathy

3.4

38.0

192

581

N03AF01

ATC

carbamazepine; oral, rectal

2.9

37.9

248

900

S18

ICPC

Laceration/cut

1.6

37.8

1690

12768

WX002

NOMESCO Finland

Sedation and analgesia

1.8

37.7

847

5317

SPAT1229

SPAT

Assessment of need for aid

2.2

37.6

401

1897

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.2

37.5

435

2139

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.9

37.5

238

847

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.9

37.3

638

3658

XF600

NOMESCO Finland

Bloodpressure measurement

2.4

37.2

330

1427

X59

ICD-10 Finland

Exposure to unspecified factor

1.8

36.9

715

4274

PEF25

NOMESCO Finland

Thrombendarterectomy of superficial femoral artery

9.4

36.9

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.6

36.8

288

1164

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.0

36.7

498

2613

C10AA01

ATC

simvastatin; oral

1.5

36.7

1900

14819

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.5

36.5

313

1330

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.8

36.3

674

3973

P20

ICPC

Memory disturbance

1.9

36.2

599

3388

C08CA01

ATC

amlodipine; oral

1.6

36.2

1516

11240

S06.0

ICD-10 Finland

Concussion

2.1

35.5

432

2167

R55

ICD-10 Finland

Syncope and collapse

2.0

35.4

504

2694

C09AA05

ATC

ramipril; oral

1.6

35.1

1095

7526

M03BX01

ATC

baclofen; systemic

5.4

35.0

108

205

R07.4

ICD-10 Finland

Chest pain, unspecified

1.6

34.9

1068

7298

NXL00

NOMESCO Finland

Biopsy of muscle

17.4

34.9

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.2

34.7

370

1749

G25.9

ICD-10 Finland

Extrapyramidal and movement disorder, unspecified

7.0

34.7

126

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

3.2

34.7

191

617

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.9

34.5

221

792

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.7

34.4

792

4993

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.6

33.9

1278

9199

N05BA04

ATC

oxazepam; oral

1.7

33.6

887

5809

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.0

33.5

460

2419

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.7

33.4

786

4978

Z02.7

ICD-10 Finland

Issue of medical certificate

2.5

33.4

275

1141

PDQ22

NOMESCO Finland

Insertion of endovascular graft into a. iliaca externa

14.5

33.2

G72.9

ICD-10 Finland

Myopathy, unspecified

8.5

33.1

J01MA02

ATC

ciprofloxacin; systemic

1.5

33.0

1518

11431

A06AD11

ATC

lactulose; oral

1.8

32.9

637

3794

T36

ICD-10 Finland

Poisoning by systemic antibiotics

3.3

32.9

171

529

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

4.2

32.9

129

315

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.7

32.9

886

5833

AAF20

NOMESCO Finland

Revision of shunt of ventricle of brain

14.2

32.8

L14

ICPC

Leg/thigh symptom/complaint

2.3

32.7

334

1545

M47.9

ICD-10 Finland

Spondylosis, unspecified

3.3

32.5

171

534

PDQ20

NOMESCO Finland

Insertion of endovascular graft into common iliac artery

9.8

32.5

R26.1

ICD-10 Finland

Paralytic gait

+∞

32.3

N06AB10

ATC

escitalopram; oral

1.8

32.0

624

3726

WX892

NOMESCO Finland

Monitored bed care

2.2

32.0

367

1793

Z71.8

ICD-10 Finland

Other specified counselling

1.7

31.9

820

5319

N05AH03

ATC

olanzapine; systemic

2.8

31.9

219

819

D64.9

ICD-10 Finland

Anaemia, unspecified

1.9

31.8

482

2632

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

31.7

1299

9500

XA402

NOMESCO Finland

ENMG

3.9

31.7

133

346

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.3

31.6

316

1448

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.6

31.4

995

6830

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.8

31.3

559

3239

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.9

31.3

472

2573

ZXA10

NOMESCO Finland

Bilateral

1.7

31.3

786

5066

A10BA02

ATC

metformin; oral

1.6

31.1

1166

8340

R03BB04

ATC

tiotropium bromide; inhalant

2.0

30.9

460

2494

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.0

30.9

458

2482

T90

ICPC

Diabetes non-insulin dependent

1.6

30.8

949

6461

R1250

NOMESCO Finland

Evaluation of functional capability

4.3

30.7

117

278

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.2

30.7

321

1502

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.6

30.6

1005

6951

A10AE04

ATC

insulin glargine; parenteral

2.0

30.5

413

2160

PEH57

NOMESCO Finland

Bypass from femoral artery to popliteal artery below knee

6.9

30.3

114

G91.9

ICD-10 Finland

Hydrocephalus, unspecified

12.7

30.3

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.3

30.2

287

1283

PD3AT

NOMESCO Finland

Pelvic artery PTA

8.1

30.0

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

30.0

810

5321

R02

ICPC

Shortness of breath/dyspnoea

1.9

29.9

500

2828

PEH56

NOMESCO Finland

Bypass from femoral to popliteal artery above knee

6.6

29.7

121

I73.9

ICD-10 Finland

Peripheral vascular disease, unspecified

6.1

29.1

136

N18

ICPC

Paralysis/weakness

4.0

29.1

119

303

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.7

29.1

665

4160

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

5.2

29.0

177

G40.9

ICD-10 Finland

Epilepsy, unspecified

3.2

28.8

157

504

A06AC01

ATC

ispaghula (psylla seeds); oral

1.6

28.8

900

6134

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.9

28.7

425

2299

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

2.1

28.6

360

1823

UKC02

NOMESCO Finland

Cystoscopy

1.7

28.4

720

4636

SPAT1231

SPAT

Assessment of adjustments needed in living environment

3.7

28.1

125

342

C10AX09

ATC

ezetimibe; oral

1.9

28.1

460

2577

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

2.3

28.1

272

1225

C10AA07

ATC

rosuvastatin; oral

1.6

27.8

932

6458

R11

ICD-10 Finland

Nausea and vomiting

2.1

27.5

326

1610

TAA40

NOMESCO Finland

Cathetrisation of cerebrospinal fluid through skin

16.5

27.5

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.7

27.4

665

4224

SPAT1254

SPAT

Administration of medicine

1.7

27.4

618

3841

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.4

27.4

250

1096

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.7

27.3

201

782

G82.2

ICD-10 Finland

Paraplegia, unspecified

11.0

27.2

I70.9

ICD-10 Finland

Generalized and unspecified atherosclerosis

3.7

26.9

121

335

N07BA03

ATC

varenicline; oral

2.8

26.7

179

659

M03BC01

ATC

orphenadrine (citrate); systemic

1.6

26.7

730

4792

R35

ICD-10 Finland

Polyuria

2.2

26.7

288

1364

R52.2

ICD-10 Finland

Other chronic pain

3.2

26.6

144

460

G04CA02

ATC

tamsulosin; oral

1.5

26.6

1047

7520

PAN14

NOMESCO Finland

Plastic repair of arteries internal carotid artery

6.6

26.6

106

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

2.4

26.6

244

1072

G62.8

ICD-10 Finland

Other specified polyneuropathies

7.2

26.5

M25.5

ICD-10 Finland

Pain in joint

1.6

26.5

926

6468

N06AA09

ATC

amitriptyline; systemic

2.0

26.4

370

1954

PEP25

NOMESCO Finland

Percutaneous plastic repair of superficial femoral artery

13.3

26.4

103

Kela drug reimbursment

Diabetes, insulin-treated

1.5

26.4

1106

8055

N05AN01

ATC

lithium; oral

4.2

26.3

102

248

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.9

26.1

167

598

R03AC02

ATC

salbutamol; inhalant

1.4

26.1

1822

14728

R33

ICD-10 Finland

Retention of urine

2.0

26.0

379

2032

C07AA05

ATC

propranolol; systemic

1.7

26.0

608

3815

W19

ICD-10 Finland

Unspecified fall

1.9

25.9

388

2105

M47.1

ICD-10 Finland

Other spondylosis with myelopathy

5.1

25.9

166

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

3.5

25.8

123

357

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

2.5

25.8

209

859

ABC60

NOMESCO Finland

Decompression of cervical spinal cord

7.9

25.6

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

5.4

25.5

148

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.7

25.2

607

3841

EBA00

NOMESCO Finland

Extraction of tooth

1.5

25.0

1131

8360

N06AB03

ATC

fluoxetine; oral

1.8

25.0

441

2535

M79.7

ICD-10 Finland

Fibromyalgia

3.7

25.0

112

310

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.7

24.9

621

3964

I65.2

ICD-10 Finland

Occlusion and stenosis of carotid artery

3.2

24.8

135

434

I70

ICD-10 Finland

Atherosclerosis

7.8

24.7

M79.0

ICD-10 Finland

Rheumatism, unspecified

3.2

24.6

135

436

SPAT1212

SPAT

Extensive examination of musculoskeletal system

2.1

24.6

309

1562

S01.0

ICD-10 Finland

Open wound of scalp

2.0

24.6

314

1601

N02AA05

ATC

oxycodone; systemic

1.7

24.5

597

3784

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

3.3

24.4

124

379

N04BC05

ATC

pramipexole; oral

2.1

24.4

301

1511

Z50.1

ICD-10 Finland

Other physical therapy

2.3

24.3

242

1104

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.7

24.3

587

3714

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.9

24.2

369

2013

N87

ICPC

Parkinsonism

4.5

24.2

197

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.9

24.1

154

551

P01AB01

ATC

metronidazole; oral, rectal

1.5

24.0

1296

9914

M03BX02

ATC

tizanidine; oral

1.4

24.0

1988

16485

H02AB06

ATC

prednisolone; systemic

1.4

23.7

1695

13666

G35

ICD-10 Finland

Multiple sclerosis

5.3

23.7

140

U04

ICPC

Incontinence urine

2.4

23.6

205

875

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.5

23.6

907

6450

110

Kela drug reimbursment

Parkinson's disease and comparable movement disrorders

2.9

23.6

147

518

R52.9

ICD-10 Finland

Pain, unspecified

2.0

23.6

312

1612

I95.1

ICD-10 Finland

Orthostatic hypotension

2.6

23.5

175

685

G81.9

ICD-10 Finland

Hemiplegia, unspecified

5.5

23.5

129

H25.1

ICD-10 Finland

Senile nuclear cataract

1.5

23.4

1107

8233

R50.9

ICD-10 Finland

Fever, unspecified

1.7

23.3

533

3316

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.6

23.2

174

686

PAF14

NOMESCO Finland

Thrombendarterectomy of internal carotid artery

3.7

23.2

102

278

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

6.5

23.1

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

23.0

1399

10929

S29

ICPC

Skin symptom/complaint other

1.6

22.9

643

4231

G44.2

ICD-10 Finland

Tension-type headache

1.8

22.9

413

2388

D11

ICPC

Diarrhoea

1.9

22.9

354

1940

P29

ICPC

Psychological sympt/compl other

2.6

22.8

169

663

N07BB01

ATC

disulfiram; oral

2.7

22.7

155

578

U05

ICPC

Urination problems other

2.4

22.7

204

885

A10BH01

ATC

sitagliptin; oral

1.8

22.6

405

2334

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.5

22.5

976

7117

L19

ICPC

Muscle symptom/complaint NOS

3.2

22.5

120

381

L02

ICPC

Back symptom/complaint

2.0

22.4

311

1635

R5599

NOMESCO Finland

Other rehabilitation service

3.1

22.4

125

410

AA7AA

NOMESCO Finland

Liquor cerebri shunt X-ray examinatin without contrast

13.1

22.4

R07.3

ICD-10 Finland

Other chest pain

1.9

22.4

350

1925

N05AA02

ATC

levomepromazine; systemic

2.6

22.4

162

627

G91.0

ICD-10 Finland

Communicating hydrocephalus

8.1

22.4

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

3.8

22.3

257

J01EA01

ATC

trimethoprim; systemic

1.5

22.3

876

6250

AA1AA

NOMESCO Finland

Head X-ray examination

5.7

22.3

113

K29

ICPC

Cardiovascular sympt/complt other

2.4

22.3

202

882

NA2CG

NOMESCO Finland

Thoracal spine extensive MRI examination with high intensity magnet

6.2

22.2

R25.2

ICD-10 Finland

Cramp and spasm

4.2

22.2

205

B01AB05

ATC

enoxaparin; parenteral

1.4

21.8

1149

8707

M79.1

ICD-10 Finland

Myalgia

1.8

21.8

410

2404

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

3.5

21.6

101

290

J01FF01

ATC

clindamycin; systemic

1.5

21.5

945

6899

A02BC01

ATC

omeprazole; systemic

1.5

21.5

1033

7683

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.7

21.4

155

598

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

5.3

21.4

127

SPAT1262

SPAT

Handing over of treatment supplies

1.6

21.4

726

5002

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

4.1

21.3

208

SAA01

NOMESCO Finland

Simple examination of mouth

1.4

21.3

2306

19845

R13

ICD-10 Finland

Dysphagia

2.1

21.3

263

1321

H53.1

ICD-10 Finland

Subjective visual disturbances

2.2

21.2

229

1086

D01

ICPC

Abdominal pain/cramps general

1.8

21.1

363

2063

U02

ICPC

Urinary frequency/urgency

1.7

21.0

460

2823

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.5

21.0

975

7194

XKD00

NOMESCO Finland

Uroflowmetry

1.5

20.9

711

4901

K02.1

ICD-10 Finland

Caries of dentine

1.4

20.9

1815

15030

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

3.4

20.7

101

300

A99

ICPC

Disease/condition unspecnature/site

1.9

20.7

325

1786

A98

ICPC

Health maint/preventive medicine

1.6

20.6

3635

34205

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.5

20.6

775

5463

P03

ICPC

Feeling depressed

2.1

20.6

247

1227

AA5EN

NOMESCO Finland

Brain reseptor or transprot protein distribution isotope imaging

15.8

20.5

PDP22

NOMESCO Finland

Percutaneous plastic repair of a. iliaca externa

15.8

20.5

NJ3CG

NOMESCO Finland

Extensive MRI examination of extremities with median high magnet

12.0

20.5

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.6

20.4

620

4153

L86

ICPC

Back syndrome with radiating pain

2.2

20.4

221

1050

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.9

20.4

296

1584

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

2.2

20.4

220

1043

R5110

SPAT

2.9

20.3

128

456

J45.9

ICD-10 Finland

Asthma, unspecified

1.6

20.3

635

4285

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.7

20.1

435

2655

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.7

20.1

473

2961

S21

ICPC

Skin texture symptom/complaint

1.7

20.0

469

2935

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.8

19.9

134

494

N05CD07

ATC

temazepam; oral

1.7

19.8

486

3076

A08

ICPC

Swelling

2.3

19.8

188

841

S22.3

ICD-10 Finland

Fracture of rib

2.0

19.7

252

1284

XPX00

NOMESCO Finland

Intraoperative angiography

7.8

19.7

AAF15

NOMESCO Finland

Ventriculoatrial shunt

11.7

19.7

S97

ICPC

Chronic ulcer skin

2.0

19.7

247

1249

G04BD08

ATC

solifenacin; oral

1.9

19.7

282

1502

SPAT1336

SPAT

Request for examination

2.4

19.6

171

734

G99.2*M47.1

ICD-10 Finland

Spondylogenic compression of spinal cord

7.7

19.5

K07

ICPC

Swollen ankles/oedema

2.2

19.5

197

908

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

4.2

19.5

178

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.7

19.4

139

533

G12.2

ICD-10 Finland

Motor neuron disease

8.2

19.4

ABC56

NOMESCO Finland

Decompression of lumbar spinal canal and nerve roots

2.8

19.3

127

464

L12

ICPC

Hand/finger symptom/complaint

1.6

19.1

490

3141

G23.9

ICD-10 Finland

Degenerative disease of basal ganglia, unspecified

20.1

19.0

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.7

19.0

431

2667

P01

ICPC

Feeling anxious/nervous/tense

2.0

19.0

264

1389

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

3.3

19.0

300

N06AB06

ATC

sertraline; oral

1.8

19.0

325

1842

F44.4

ICD-10 Finland

Dissociative motor disorders

55.3

18.9

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.6

18.9

506

3277

N05AB03

ATC

perphenazine; systemic, rectal

2.7

18.9

128

476

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

3.1

18.8

105

346

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.5

18.7

878

6471

N05AX08

ATC

risperidone; systemic

1.9

18.7

286

1560

A02BA02

ATC

ranitidine; systemic

1.5

18.7

728

5157

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.5

18.7

890

6581

M47.82

ICD-10 Finland

Other spondylosis, cervical region

2.5

18.6

153

637

K05.31

ICD-10 Finland

Periodontitis pronounced

1.8

18.6

352

2061

R90.8

ICD-10 Finland

Other abnormal findings on diagnostic imaging of central nervous system

6.0

18.5

Z01.9

ICD-10 Finland

Special examination, unspecified

2.1

18.5

218

1073

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.9

18.4

284

1555

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.4

18.4

1518

12375

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

5.0

18.3

120

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.9

18.2

297

1658

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.5

18.2

608

4160

U28

ICPC

Limited function/disability (U)

4.3

18.2

157

XPX08

NOMESCO Finland

Intraoperative flow measurement

4.4

18.1

148

M05BA04

ATC

alendronic acid; oral

1.8

18.1

327

1885

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

2.9

18.1

114

405

N03AF02

ATC

oxcarbazepine; oral

2.8

18.0

116

420

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.4

17.9

1059

8142

U07

ICPC

Urine symptom/complaint other

2.0

17.9

231

1179

UJF32

NOMESCO Finland

Coloscopy

1.4

17.9

950

7164

QD9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in lower extremities, unspecified

5.2

17.8

107

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.0

17.8

241

1256

P76

ICPC

Depressive disorder

2.3

17.7

172

778

XF606

NOMESCO Finland

Ortostatic test

6.2

17.7

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.3

17.7

1753

14681

NJ3BG

NOMESCO Finland

MRI examination of extremities with high intensity magnet

11.1

17.7

K90

ICPC

Stroke/cerebrovascular accident

2.5

17.6

139

565

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.7

17.6

392

2412

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

5.5

17.6

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.0

17.6

229

1177

P06

ICPC

Sleep disturbance

1.8

17.4

307

1758

R60.9

ICD-10 Finland

Oedema, unspecified

2.1

17.4

192

920

SPAT1234

SPAT

Support of social functional capacity

2.1

17.4

208

1033

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.9

17.3

254

1365

J01MA12

ATC

levofloxacin; systemic

1.5

17.3

695

4951

PEQ25

NOMESCO Finland

Insertion of endovascular graft into superficial femoral artery

42.2

17.3

G47.3

ICD-10 Finland

Sleep apnoea

1.5

17.3

692

4926

L16

ICPC

Ankle symptom/complaint

1.7

17.2

364

2206

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

4.2

17.2

156

R41.3

ICD-10 Finland

Other amnesia

2.6

17.2

124

481

A46

ICD-10 Finland

Erysipelas

1.6

17.2

537

3611

A02BC05

ATC

esomeprazole; systemic

1.4

17.2

1370

11075

R29.6

ICD-10 Finland

Tendency to fall, not elsewhere classified

14.8

17.1

EBA30

NOMESCO Finland

Excision of root of tooth

2.1

17.0

205

1018

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.7

17.0

370

2261

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

5.6

17.0

J01CA04

ATC

amoxicillin; systemic

1.4

16.9

2856

25862

A11

ICPC

Chest pain NOS

1.8

16.9

288

1630

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.8

16.8

107

382

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.1

16.8

195

955

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

6.3

16.8

R4130

NOMESCO Finland

Speech therapy

2.8

16.8

107

384

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

3.6

16.7

215

XCK10

NOMESCO Finland

Photography of fundus of eye

1.7

16.7

401

2520

N05BA06

ATC

lorazepam; systemic, sublingual

2.1

16.6

198

981

Z72.0

ICD-10 Finland

Tobacco use

3.0

16.6

317

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

4.8

16.6

116

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.7

16.6

351

2126

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.2

16.6

164

748

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

6.1

16.6

J01DA01

ATC

[U] cefalexin; systemic

1.3

16.6

2170

18876

G25.0

ICD-10 Finland

Essential tremor

2.9

16.5

102

360

N01

ICPC

Headache

1.8

16.5

311

1817

F61.0

ICD-10 Finland

Mixed personality disorders

4.5

16.5

130

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.9

16.5

250

1358

W10

ICD-10 Finland

Fall on and from stairs and steps

2.1

16.3

180

865

J01CA08

ATC

pivmecillinam; oral

1.4

16.3

1152

9113

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.2

16.2

174

824

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

1.8

16.2

289

1661

K85

ICPC

Elevated blood pressure

1.5

16.2

544

3719

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

3.0

16.2

313

S70.0

ICD-10 Finland

Contusion of hip

2.4

16.1

139

594

N32.82

ICD-10 Finland

Instability of the detrusor vesicae muscle

3.6

16.1

202

G11.2

ICD-10 Finland

Late-onset cerebellar ataxia

47.7

16.0

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.6

16.0

120

477

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.5

15.8

645

4599

A02BC03

ATC

lansoprazole; oral

1.4

15.8

1006

7807

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.7

15.8

110

418

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

3.9

15.8

170

D06

ICPC

Abdominal pain localized other

1.8

15.8

265

1493

R1260

NOMESCO Finland

Evaluation of communicative skills

3.0

15.7

301

XKC03

NOMESCO Finland

Water cystometry

2.5

15.7

127

526

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.5

15.7

598

4205

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.7

15.7

106

397

H02AB07

ATC

prednisone; oral

1.5

15.6

506

3428

TAB22

NOMESCO Finland

Stoppin epidural fluid escape with coagulated blood

7.0

15.6

I67.3

ICD-10 Finland

Progressive vascular leukoencephalopathy

3.6

15.6

202

L13

ICPC

Hip symptom/complaint

1.5

15.6

568

3953

G04BD07

ATC

tolterodine; oral

2.0

15.5

211

1102

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.7

15.5

339

2076

J01FA06

ATC

roxithromycin; oral

1.3

15.3

1337

10904

K59.09

ICD-10 Finland

Constipation, unspecified

1.9

15.3

243

1343

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

2.6

15.3

108

415

M70.6

ICD-10 Finland

Trochanteric bursitis

1.6

15.3

394

2524

N31.9

ICD-10 Finland

Neuromuscular dysfunction of bladder, unspecified

4.9

15.2

101

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.3

15.2

146

657

H53.2

ICD-10 Finland

Diplopia

2.5

15.1

121

498

TKC22

NOMESCO Finland

Catheterisation instruction

2.7

15.1

102

380

E86

ICD-10 Finland

Volume depletion

2.6

15.1

111

437

F10.09

ICD-10 Finland

Alcohol intoxication UNS

3.3

15.1

240

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

15.0

2031

17636

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.5

15.0

579

4079

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

2.2

15.0

148

677

G61.0

ICD-10 Finland

Guillain-Barré syndrome

8.5

14.9

C01DA14

ATC

isosorbide mononitrate; oral

1.5

14.9

668

4850

G37.9

ICD-10 Finland

Demyelinating disease of central nervous system, unspecified

7.6

14.8

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.9

14.8

208

1101

N03AX11

ATC

topiramate; oral

3.2

14.8

249

G72.8

ICD-10 Finland

Other specified myopathies

3.3

14.7

233

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

14.7

1661

14048

AB18W

NOMESCO Finland

16.5

14.7

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.4

14.7

127

544

X58

ICD-10 Finland

Exposure to other specified factors

1.6

14.7

420

2759

N05AX12

ATC

aripiprazole; systemic

2.8

14.6

347

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

2.5

14.6

114

463

RS221

NOMESCO Finland

3.4

14.6

203

G99.2

ICD-10 Finland

Myelopathy in diseases classified elsewhere

7.7

14.6

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.4

14.6

1106

8815

L05

ICPC

Flank/axilla symptom/complaint

2.0

14.5

197

1028

R06AE07

ATC

cetirizine; oral

1.3

14.5

1350

11095

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

3.0

14.5

291

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

3.0

14.5

278

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.3

14.5

1238

10050

R63.4

ICD-10 Finland

Abnormal weight loss

2.3

14.5

137

615

R29.2

ICD-10 Finland

Abnormal reflex

36.1

14.4

KCV12

NOMESCO Finland

Urinary bladder endoscopic botulin therapy

4.9

14.4

A91

ICPC

Abnormal result investigation NOS

2.1

14.4

161

778

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.9

14.4

204

1083

R5140

NOMESCO Finland

Monitoring the use of the aid

1.6

14.4

343

2151

R52.0

ICD-10 Finland

Acute pain

2.5

14.4

110

443

G43.9

ICD-10 Finland

Migraine, unspecified

2.3

14.4

131

578

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.7

14.4

336

2095

K08.3

ICD-10 Finland

Retained dental root

1.8

14.3

253

1449

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.8

14.3

240

1351

K92

ICPC

Atherosclerosis/periph vascular dis

3.3

14.3

222

E0000UV

ATC

1.3

14.3

1314

10781

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.5

14.2

594

4251

F34.1

ICD-10 Finland

Dysthymia

2.6

14.2

101

390

A03

ICPC

Fever

1.5

14.1

465

3162

WX320

NOMESCO Finland

Spinalanesthesy

1.4

14.1

812

6177

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.5

14.1

500

3459

R47.8

ICD-10 Finland

Other and unspecified speech disturbances

4.8

14.0

L84

ICD-10 Finland

Corns and callosities

2.3

14.0

128

565

KMAK

NOMESCO Finland

1.3

14.0

1543

12978

R32

ICD-10 Finland

Unspecified urinary incontinence

2.5

13.9

112

461

K59.0

ICD-10 Finland

Constipation

1.9

13.9

208

1127

K43

ICPC

Cardiovascular, Other diagnostic procedure

3.5

13.9

190

K59.1

ICD-10 Finland

Functional diarrhoea

2.0

13.9

184

955

T85.0

ICD-10 Finland

Mechanical complication of ventricular intracranial (communicating) shunt

12.7

13.9

WX290

NOMESCO Finland

Other blockade of nerve

1.3

13.8

1231

10035

XF404

NOMESCO Finland

Ambulatory ECG

1.6

13.8

362

2325

G91.1

ICD-10 Finland

Obstructive hydrocephalus

7.8

13.8

D12

ICPC

Constipation

2.2

13.8

137

628

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.3

13.8

1729

14794

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.3

13.8

1403

11660

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.9

13.8

193

1022

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.5

13.7

449

3044

WVA20

NOMESCO Finland

Medicine administration

2.8

13.7

325

P99

ICPC

Psychological disorders other

3.0

13.7

268

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.7

13.7

292

1775

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

13.7

1197

9731

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

13.7

1307

10763

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.6

13.6

368

2382

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.8

13.6

311

M02AA07

ATC

piroxicam; topical

1.3

13.6

1267

10398

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.6

13.5

379

2475

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

2.0

13.5

166

837

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.2

13.5

142

669

M99.3

ICD-10 Finland

Osseous stenosis of neural canal

8.8

13.4

X57

ICD-10 Finland

Unspecified privation

2.6

13.4

100

397

N30

ICD-10 Finland

Cystitis

1.8

13.4

226

1276

SPAT1301

SPAT

No procedures

1.3

13.3

1137

9206

E000003

ATC

2.1

13.3

157

775

L01

ICPC

Neck symptom/complaint

1.5

13.3

413

2769

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.6

13.2

388

2565

PD4CC

NOMESCO Finland

Very extensive arterigography of lower extremity with X-ray

4.5

13.2

104

N06AX03

ATC

mianserin; oral

2.0

13.2

165

836

IGY02

NOMESCO Finland

Psychiatric monitoring contact

3.0

13.1

251

N31.8

ICD-10 Finland

Other neuromuscular dysfunction of bladder

6.9

13.1

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

4.3

13.1

109

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

1.9

13.1

188

1005

F99

ICD-10 Finland

Mental disorder, not otherwise specified

3.3

13.1

194

I50.9

ICD-10 Finland

Heart failure, unspecified

1.5

13.1

566

4073

S22

ICPC

Nail symptom/complaint

1.8

13.1

220

1240

J46

ICD-10 Finland

Status asthmaticus

2.5

13.0

101

410

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.7

13.0

269

1619

A07AA02

ATC

nystatin; oral

1.8

13.0

227

1298

D09

ICPC

Nausea

2.2

13.0

134

626

G04BD11

ATC

fesoterodine; oral

2.3

12.9

123

554

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.7

12.9

299

1861

N06AX26

ATC

vortioxetine; oral

2.1

12.9

147

716

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.7

12.8

255

1515

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.3

12.8

1664

14254

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

2.8

12.8

287

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

2.1

12.8

147

720

A10BB12

ATC

glimepiride; oral

1.6

12.8

306

1920

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.7

12.8

248

1466

G99.2*M47.9

ICD-10 Finland

Myelopathy in spondylosis

8.5

12.7

G04BD04

ATC

oxybutynin; oral, transdermal

1.8

12.7

208

1165

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.6

12.7

338

2180

C09CA06

ATC

candesartan; oral

1.4

12.7

704

5309

G24.9

ICD-10 Finland

Dystonia, unspecified

9.7

12.7

R15

ICD-10 Finland

Faecal incontinence

2.5

12.7

101

414

F10.20

ICD-10 Finland

Alcohol dependence currently independent

3.1

12.7

232

PD4BD

NOMESCO Finland

Extensive CT of lower extremity arteries

4.7

12.7

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

12.7

915

7210

A27

ICPC

Fear of other disease NOS

2.0

12.6

153

767

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.6

12.6

357

2340

G11.9

ICD-10 Finland

Hereditary ataxia, unspecified

15.4

12.6

L84

ICPC

Back syndrome without radiat pain

2.1

12.5

147

724

RS222

NOMESCO Finland

3.5

12.5

169

B03BA03

ATC

hydroxocobalamin; parenteral

1.8

12.5

226

1305

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.6

12.5

371

2460

-1

NOMESCO Finland

1.3

12.5

997

7972

205

Kela drug reimbursment

Chronic hypertension

1.3

12.5

1118

9092

SPAT1167

SPAT

Insertion of urinary catheter

2.1

12.5

142

691

N03AX14

ATC

levetiracetam; systemic

2.5

12.3

398

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

3.5

12.3

161

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

4.2

12.3

107

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.7

12.2

263

1600

PFP26

NOMESCO Finland

Percutaneous plastic repair of popliteal artery

10.5

12.2

WX110

SPAT

2.1

12.2

145

720

PD3BT

NOMESCO Finland

Pelvic artery extensive PTA

9.0

12.2

H03AA01

ATC

levothyroxine sodium; systemic

1.4

12.2

724

5523

XF402

NOMESCO Finland

ECG with work load test

1.5

12.1

413

2825

I25

ICD-10 Finland

Chronic ischaemic heart disease

1.8

12.1

208

1182

-69

ICPC

Other reason for encounter NEC

2.0

12.1

151

766

A97

ICPC

No disease

1.5

12.1

513

3678

C03DA01

ATC

spironolactone; oral

1.5

12.1

407

2779

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.6

12.1

338

SPAT1053

SPAT

Memory test

1.4

12.1

617

4579

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.7

12.0

246

1476

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

2.1

12.0

128

609

H81.4

ICD-10 Finland

Vertigo of central origin

4.5

12.0

F10.25

ICD-10 Finland

Alcohol dependence continuous use

3.2

12.0

202

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

4.0

12.0

119

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.4

12.0

766

5909

C09CA01

ATC

losartan; oral

1.3

12.0

849

6659

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

3.1

12.0

208

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

3.3

11.9

181

M01AE02

ATC

naproxen; oral, rectal

1.3

11.9

1822

15881

U29

ICPC

Urinary symptom/complaint other

2.3

11.9

111

495

N06AX12

ATC

bupropion; oral

2.1

11.9

138

680

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.4

11.9

763

5890

A50

ICPC

General and Unspecified, Medication/prescr/renewal

2.2

11.9

124

585

R05

ICPC

Cough

1.4

11.8

713

5449

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.7

11.8

227

1338

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.7

11.8

249

1511

B82

ICPC

Anaemia other/unspecified

2.3

11.8

104

451

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

5.9

11.8

G95.9

ICD-10 Finland

Disease of spinal cord, unspecified

10.5

11.7

M01AH01

ATC

celecoxib; oral (coxibs)

1.4

11.7

585

4322

D07AB08

ATC

desonide; topical

1.6

11.7

336

2208

SPAT1342

SPAT

Referral to specialised care

3.3

11.6

169

PET23

NOMESCO Finland

Injection of therapeutic agent into or percutaneous occlusion of femoral artery

65.1

11.6

R25.8

ICD-10 Finland

Other and unspecified abnormal involuntary movements

19.0

11.6

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

11.6

255

1565

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.3

11.6

1212

10058

PG3YT

NOMESCO Finland

Other artery stentgraft therapy

22.9

11.6

K30

ICD-10 Finland

Functional dyspepsia

1.6

11.5

315

2044

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.0

11.5

142

716

M03BC51

ATC

orphenadrine, combinations; systemic

1.3

11.5

815

6389

B81

ICPC

Anaemia vit B12/folate deficiency

2.0

11.5

153

797

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.7

11.5

264

1638

N30.9

ICD-10 Finland

Cystitis, unspecified

1.8

11.5

192

1084

F44.9

ICD-10 Finland

Dissociative [conversion] disorder, unspecified

9.2

11.5

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

2.7

11.4

273

H01BA02

ATC

desmopressin; nasal, systemic, sublingual

2.7

11.4

291

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.4

11.4

156

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

1.9

11.4

174

954

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

3.3

11.4

172

C10AA04

ATC

fluvastatin; oral

1.5

11.4

358

2406

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.7

11.3

253

1559

E000001

ATC

1.4

11.3

640

4834

Z03

ICPC

Housing/neighbourhood problem

5.4

11.3

E66.00

ICD-10 Finland

Metabolic syndrome

1.9

11.3

175

963

Z29

ICPC

Social problem NOS

2.8

11.3

257

L60.0

ICD-10 Finland

Ingrowing nail

2.0

11.2

144

738

R03DC03

ATC

montelukast; oral

1.5

11.2

448

3172

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

2.3

11.1

103

458

N05AF03

ATC

chlorprothixene; systemic

2.5

11.1

343

G62.1

ICD-10 Finland

Alcoholic polyneuropathy

7.6

11.1

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

3.7

11.1

128

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

2.7

11.1

284

U13

ICPC

Bladder symptom/complaint other

2.2

11.1

113

526

WZC30

NOMESCO Finland

Teaching

1.5

11.1

437

3085

EBA15

NOMESCO Finland

Extraction of large number of teeth

2.0

11.1

139

709

F70.0

ICD-10 Finland

Mild mental retardation, With the statement of no, or minimal, impairment of behaviour

8.0

11.1

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

3.0

11.0

204

N88

ICPC

Epilepsy

6.1

11.0

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

2.7

11.0

279

G31.9

ICD-10 Finland

Degenerative disease of nervous system, unspecified

7.4

10.9

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

3.7

10.9

125

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.9

10.9

222

L08

ICPC

Shoulder symptom/complaint

1.4

10.9

612

4615

M35.7

ICD-10 Finland

Hypermobility syndrome

4.2

10.9

N06AA06

ATC

trimipramine; systemic

2.5

10.8

336

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

2.8

10.8

246

WX872

NOMESCO Finland

Intensive care

1.8

10.7

194

1120

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

2.0

10.7

136

694

J01FA01

ATC

erythromycin; systemic

1.5

10.7

364

2487

AN1

Coronary angiography

1.4

10.7

464

3335

NF1AA

NOMESCO Finland

Hip X-ray examination

1.6

10.7

312

2058

R25.3

ICD-10 Finland

Fasciculation

21.5

10.7

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

2.0

10.6

131

662

H04.10

ICD-10 Finland

Dry eye syndrome

1.6

10.6

293

1906

K28

ICPC

Limited function/disability (K)

2.3

10.6

410

M54.8

ICD-10 Finland

Other dorsalgia

2.1

10.6

122

600

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.4

10.6

496

3616

SPAT1050

SPAT

Extensive neurological examination

2.4

10.6

353

A05

ICPC

Feeling ill

1.8

10.6

180

1021

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

2.8

10.6

244

M01AB05

ATC

diclofenac; systemic, rectal

1.2

10.6

2177

19543

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

4.3

10.5

Z09.4

ICD-10 Finland

Follow-up examination after treatment of fracture

1.9

10.5

147

780

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

4.8

10.5

L29.9

ICD-10 Finland

Pruritus, unspecified

2.5

10.5

337

XKD03

NOMESCO Finland

Urethral pressure profilometry

2.4

10.5

386

R30.0

ICD-10 Finland

Dysuria

2.1

10.4

121

598

J45

ICD-10 Finland

Asthma

1.6

10.4

300

1974

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

2.7

10.4

264

R10.0

ICD-10 Finland

Acute abdomen

2.2

10.4

103

473

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.4

10.4

446

3202

M54.3

ICD-10 Finland

Sciatica

1.8

10.4

182

1044

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.9

10.3

141

740

PFH60

NOMESCO Finland

Bypass from femoral or popliteal artery to tibioperoneal trunk

32.6

10.3

M10.9

ICD-10 Finland

Gout, unspecified

1.6

10.3

249

1570

J02AC01

ATC

fluconazole; systemic

1.3

10.3

1080

8938

M96.1

ICD-10 Finland

Postlaminectomy syndrome, not elsewhere classified

4.6

10.3

N05BA09

ATC

clobazam; oral

5.7

10.2

F06.7

ICD-10 Finland

Mild cognitive disorder

2.1

10.2

108

514

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

2.2

10.2

102

471

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.6

10.2

294

1934

F60.9

ICD-10 Finland

Personality disorder, unspecified

4.0

10.2

F03

ICD-10 Finland

Unspecified dementia

1.8

10.2

162

902

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.6

10.2

274

1775

M01AE01

ATC

ibuprofen; systemic, rectal

1.3

10.1

3083

28905

UJF30

NOMESCO Finland

Ileoscopy through colon

1.6

10.1

292

1921

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

1.6

10.1

234

1454

A69

ICPC

General and Unspecified, Other reason for encounter NEC

2.2

10.1

101

466

SPAT1240

SPAT

Therapeutic discussion

1.6

10.1

261

1672

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

2.0

10.1

123

621

F51.0

ICD-10 Finland

Nonorganic insomnia

1.5

10.1

323

2179

A62

ICPC

General and Unspecified, Administrative procedure

2.2

10.1

443

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.7

10.1

219

1340

R21

ICPC

Throat symptom/complaint

1.4

10.1

515

3819

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.5

10.0

328

2222

N06AG02

ATC

moclobemide; oral

1.9

10.0

143

765

Z08

ICPC

Social welfare problem

3.4

10.0

140

S00.0

ICD-10 Finland

Superficial injury of scalp

2.5

10.0

319

M43.1

ICD-10 Finland

Spondylolisthesis

2.0

10.0

124

629

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

2.5

10.0

302

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.2

10.0

103

484

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.1

9.9

105

498

R03AK07

ATC

formoterol and budesonide; inhalant

1.4

9.9

544

4078

N06AA12

ATC

doxepin; systemic

1.8

9.9

178

1029

D10

ICPC

Vomiting

1.9

9.9

138

732

R29

ICPC

Respiratory symptom/complaint other

1.7

9.9

190

1119

K92.1

ICD-10 Finland

Melaena

1.7

9.9

197

1174

N05BA02

ATC

chlordiazepoxide; systemic

2.3

9.9

391

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.1

9.9

110

535

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.6

9.9

232

1450

M54.2

ICD-10 Finland

Cervicalgia

1.7

9.9

202

1215

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

2.0

9.9

129

666

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

2.6

9.9

262

G31.0

ICD-10 Finland

Circumscribed brain atrophy

5.0

9.8

Z31.5

ICD-10 Finland

Genetic counselling

2.0

9.8

121

614

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

1.9

9.8

131

684

F31.8

ICD-10 Finland

Other bipolar affective disorders

3.4

9.8

132

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

2.5

9.8

291

K92.0

ICD-10 Finland

Haematemesis

2.2

9.8

416

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

5.7

9.8

SPAT1070

SPAT

Doppler ultrasound examination of blood flow in arteries of lower extremity

2.4

9.8

357

SPAT1307

SPAT

Psychosocial counselling and guidance

1.9

9.7

147

804

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

9.7

1312

11178

J01AA02

ATC

doxycycline; systemic

1.2

9.7

2698

24929

R04.0

ICD-10 Finland

Epistaxis

1.6

9.7

263

1708

AB14W

NOMESCO Finland

7.4

9.7

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.4

9.7

454

3314

G43.3

ICD-10 Finland

Complicated migraine

3.7

9.7

108

R27.8

ICD-10 Finland

Other and unspecified lack of coordination

55.1

9.6

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.3

9.6

403

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

1.5

9.6

313

2119

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

3.5

9.6

124

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.2

9.6

438

T08

ICPC

Weight loss

2.8

9.6

216

S10

ICPC

Boil/carbuncle

1.7

9.5

178

1043

G63.2*E10.4

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic polyneuropathy

6.3

9.5

D07AA02

ATC

hydrocortisone; topical

1.4

9.5

410

2941

R31

ICD-10 Finland

Unspecified haematuria

1.5

9.5

370

2605

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

9.5

2242

20324

EBA10

NOMESCO Finland

Surgical removal of tooth

1.5

9.5

298

2002

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

9.4

846

6839

E87.6

ICD-10 Finland

Hypokalaemia

2.0

9.4

109

540

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

2.4

9.4

323

S80.0

ICD-10 Finland

Contusion of knee

1.7

9.4

177

1040

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

1.9

9.4

126

661

TNX99

NOMESCO Finland

Other orthopaedic minor procedure

2.1

9.4

101

483

N06DA03

ATC

rivastigmine; oral, transdermal

1.9

9.4

140

764

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

2.5

9.4

270

F31.5

ICD-10 Finland

Bipolar affective disorder, current episode severe depression with psychotic symptoms

5.6

9.3

I702, L97

ICD-10 Finland

6.9

9.3

J01MA14

ATC

moxifloxacin; systemic

1.5

9.3

287

1919

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

1.8

9.3

158

901

TAW99

NOMESCO Finland

Other minor neurosurgical procedure

4.9

9.3

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

2.2

9.2

421

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

1.6

9.2

225

1424

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

5.2

9.2

ABD32

NOMESCO Finland

Implantation of temporary spinal stimulation device

6.0

9.2

JN3AD

NOMESCO Finland

Abdominal CT examination

1.6

9.2

248

1607

M41.9

ICD-10 Finland

Scoliosis, unspecified

3.2

9.2

145

S20.2

ICD-10 Finland

Contusion of thorax

1.8

9.2

153

865

N27

ICPC

Fear of neurological disease other

2.8

9.1

196

3AC01

NOMESCO Finland

3.2

9.1

140

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.4

9.1

457

3374

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

1.9

9.1

121

630

A01AB09

ATC

miconazole; local oral

1.5

9.1

288

1938

PA6AE

NOMESCO Finland

Ulrasound examination of neck vasculature

3.1

9.1

157

WW200

NOMESCO Finland

Immunization

2.2

9.1

418

N04AA02

ATC

biperiden; systemic

2.6

9.1

238

G57.3

ICD-10 Finland

Lesion of lateral popliteal nerve

2.8

9.0

207

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.3

9.0

757

6059

H01

ICPC

Ear pain/earache

1.5

9.0

299

2035

H81

ICPC

Excessive ear wax

1.3

9.0

591

4562

M01AH05

ATC

etoricoxib; oral

1.2

9.0

1785

15842

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.6

9.0

237

1527

K91

ICPC

Cerebrovascular disease

2.6

9.0

246

TNG34

NOMESCO Finland

Major custom moulded orthopaedic cast, knee or lower leg

2.9

9.0

186

183

Kela drug reimbursment

Lamotrigin and topiramate

3.8

9.0

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

9.0

1155

9769

N05AC02

ATC

thioridazine; oral

2.5

9.0

275

S01

ICPC

Pain/tenderness of skin

1.9

9.0

134

729

I69.8

ICD-10 Finland

Sequelae of other and unspecified cerebrovascular diseases

4.9

9.0

WX212

NOMESCO Finland

Femoral plexus blockade

2.3

9.0

341

J01FA09

ATC

clarithromycin; systemic

1.3

8.9

916

7532

N05CF02

ATC

zolpidem; oral

1.4

8.9

488

3656

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.5

8.9

265

1758

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

3.5

8.9

111

H3603, E103

ICD-10 Finland

3.8

8.9

N17.9

ICD-10 Finland

Acute renal failure, unspecified

1.8

8.9

143

799

N05BA12

ATC

alprazolam; oral

1.5

8.9

288

1950

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

2.6

8.8

253

M54

ICD-10 Finland

Dorsalgia

1.5

8.8

318

2200

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

2.7

8.8

228

N06AA10

ATC

nortriptyline; systemic

2.5

8.8

271

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

2.3

8.8

348

T89

ICPC

Diabetes insulin dependent

2.0

8.8

113

584

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.8

8.8

141

789

WX140

NOMESCO Finland

Parabulbar anesthesy

1.8

8.8

155

892

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

2.7

8.8

213

A41.9

ICD-10 Finland

Sepsis, unspecified

1.8

8.8

133

730

F48.0

ICD-10 Finland

Neurasthenia

10.7

8.8

D21

ICPC

Swallowing problem

2.7

8.7

220

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

2.1

8.7

439

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.2

8.7

1269

10885

JN4BD

NOMESCO Finland

Extensive body CT

1.4

8.7

388

2808

C08CA13

ATC

lercanidipine; oral

1.4

8.6

441

3266

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

4.5

8.6

A10AE05

ATC

insulin detemir; parenteral

1.7

8.6

190

1169

L99

ICPC

Musculoskeletal disease other

2.5

8.6

251

TNH33

NOMESCO Finland

Custom moulded brace, ankle or foot

2.6

8.6

226

M05BA07

ATC

risedronic acid; oral

2.0

8.6

111

572

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

1.9

8.6

116

611

I20.09

ICD-10 Finland

Unstable angina

1.6

8.6

214

1358

R41.0

ICD-10 Finland

Disorientation, unspecified

2.0

8.6

113

586

B01AA03

ATC

warfarin; systemic

1.3

8.6

797

6464

R47.1

ICD-10 Finland

Dysarthria and anarthria

3.3

8.6

125

-62

ICPC

Administrative procedure

2.1

8.6

470

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

2.5

8.6

252

F31

ICD-10 Finland

Bipolar affective disorder

3.7

8.6

G99.2*M50.0

ICD-10 Finland

Cervical disc disorder with myelopathy

5.5

8.6

EB1AA

SPAT

1.8

8.6

135

752

H81.9

ICD-10 Finland

Disorder of vestibular function, unspecified

3.1

8.5

142

R49.03

ICD-10 Finland

Atrophic dysphonia

2.9

8.5

168

AAF99

NOMESCO Finland

Other shunt operation on ventricle of brain or intracerebral cyst

9.0

8.5

WYA20

NOMESCO Finland

Home visit

2.5

8.5

254

R03BA05

ATC

fluticasone; inhalant

1.3

8.5

543

4175

P72

ICPC

Schizophrenia

2.9

8.5

169

L11

ICPC

Wrist symptom/complaint

1.6

8.5

227

1471

F44.7

ICD-10 Finland

Mixed dissociative [conversion] disorders

20.0

8.5

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.4

8.4

409

3002

G21.9

ICD-10 Finland

Secondary parkinsonism, unspecified

5.4

8.4

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

5.4

8.4

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

1.7

8.4

181

1105

30180

ICD-8 Finland

Personality disorders, Immatura

5.6

8.4

J45.1

ICD-10 Finland

Nonallergic asthma

1.6

8.4

218

1399

C03AA03

ATC

hydrochlorothiazide; oral

1.4

8.4

349

2489

WYA10

NOMESCO Finland

First aid or other corresponding healthcare contact

1.6

8.4

218

1400

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

3.0

8.4

150

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

2.4

8.4

276

SPE90

NOMESCO Finland

Other fitting and preparation of partial tooth prosthesis

2.1

8.4

401

N40

ICD-10 Finland

Hyperplasia of prostate

1.3

8.4

861

7077

N86

ICPC

Multiple sclerosis

4.8

8.3

SPAT1245

SPAT

Provision of support and information to patient’s family members

1.7

8.3

172

1039

Z09.8

ICD-10 Finland

Follow-up examination after other treatment for other conditions

2.1

8.3

449

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.4

8.3

370

2673

D01AC02

ATC

miconazole; topical

1.5

8.3

266

1797

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

2.0

8.3

107

554

109

Kela drug reimbursment

Multiple sclerosis

3.9

8.3

M54.6

ICD-10 Finland

Pain in thoracic spine

1.7

8.3

173

1047

S19

ICPC

Skin injury other

1.8

8.3

136

766

SFA40

NOMESCO Finland

Replacement of krone of tooth

1.3

8.3

627

4943

ABC63

NOMESCO Finland

Decompression of thoracic spinal cord

10.7

8.3

WX882

NOMESCO Finland

High dependency care

2.0

8.3

108

560

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.4

8.2

398

2918

R05

ICD-10 Finland

Cough

1.3

8.2

605

4752

NJ3DG

NOMESCO Finland

Very extensive MRI examination of extremities with high intensity magnet

14.5

8.2

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

1.9

8.2

116

624

N06AA04

ATC

clomipramine; systemic

2.5

8.1

230

A60

ICPC

General and Unspecified, Result test/procedure

1.8

8.1

142

817

WZA90

NOMESCO Finland

Other doctors statement

1.3

8.1

686

5494

M01AX17

ATC

nimesulide; oral

1.3

8.1

803

6564

I50.0

ICD-10 Finland

Congestive heart failure

1.5

8.1

282

1939

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.3

8.1

299

ABB00

NOMESCO Finland

Excision of lesion of spinal canal

8.1

G80.2

ICD-10 Finland

Spastic hemiplegic cerebral palsy

17.2

8.1

Z74.0

ICD-10 Finland

Need for assistance due to reduced mobility

11.7

8.1

AAA20

NOMESCO Finland

Insertion of intraventricular pressure monitoring device

6.8

8.0

F82

ICD-10 Finland

Specific developmental disorder of motor function

4.8

8.0

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.9

8.0

107

563

P15

ICPC

Chronic alcohol abuse

2.2

8.0

333

NB6AA

NOMESCO Finland

Humerus X-ray examination

2.4

8.0

282

I63.5

ICD-10 Finland

Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries

2.4

8.0

263

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

3.4

8.0

111

M89.0

ICD-10 Finland

Algoneurodystrophy

4.3

8.0

R05DB05

ATC

pentoxyverine; oral, rectal

1.9

8.0

116

626

N05AH02

ATC

clozapine; systemic

2.9

8.0

166

R4190

NOMESCO Finland

Nutritional therapy

1.9

7.9

106

557

R06

ICPC

Nose bleed/epistaxis

2.1

7.9

428

A03FA02

ATC

cisapride; oral, rectal

1.5

7.9

255

1723

F32

ICD-10 Finland

Depressive episode

1.8

7.9

133

756

R06AX27

ATC

desloratadine; oral

1.3

7.9

687

5519

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.3

7.9

553

4306

L04

ICPC

Chest symptom/complaint

1.7

7.9

171

1048

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.5

7.9

250

1685

SPAT1106

SPAT

Acupuncture

4.2

7.9

L09

ICPC

Arm symptom/complaint

1.8

7.9

121

667

S72.0

ICD-10 Finland

Fracture of neck of femur

1.8

7.9

138

796

NHQ40

NOMESCO Finland

Amputation of toe

2.2

7.9

338

M48.9

ICD-10 Finland

Spondylopathy, unspecified

4.0

7.8

R01AD09

ATC

mometasone; nasal

1.2

7.8

1286

11138

M05BX04

ATC

denosumab; parenteral

1.7

7.8

155

925

F32.1

ICD-10 Finland

Moderate depressive episode

1.9

7.8

117

640

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.6

7.8

185

1161

M53.2

ICD-10 Finland

Spinal instabilities

3.8

7.8

315

Kela drug reimbursment

Clopidogrel

2.6

7.8

199

B01AF02

ATC

apixaban; oral

1.4

7.8

353

2559

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

2.1

7.8

425

NA1BM

NOMESCO Finland

Cervical spine MRI examination with 3 Tesla magnet

10.8

7.8

H57.1

ICD-10 Finland

Ocular pain

2.1

7.8

400

G04BD09

ATC

trospium; oral

2.0

7.8

462

J01CF05

ATC

flucloxacillin; systemic

1.8

7.8

126

707

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.3

7.8

547

4263

N05BE01

ATC

buspirone; oral

2.1

7.8

401

A10BK03

ATC

empagliflozin; oral

1.5

7.8

222

1464

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

1.9

7.7

116

633

M77.4

ICD-10 Finland

Metatarsalgia

1.7

7.7

142

829

U71

ICPC

Cystitis/urinary infection other

1.6

7.7

174

1077

G11.4

ICD-10 Finland

Hereditary spastic paraplegia

45.0

7.7

T66

ICPC

Metabolic, Referral to non-MD provider

5.0

7.7

R68.88

ICD-10 Finland

Other specified general symptoms and signs, not elsewhere classified.

5.0

7.7

L15

ICPC

Knee symptom/complaint

1.3

7.7

646

5166

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.7

7.7

164

1001

R1240

NOMESCO Finland

Social assessment of need and possibilities of rehabilitation

3.4

7.7

104

M62.9

ICD-10 Finland

Disorder of muscle, unspecified

5.3

7.7

R51.81

ICD-10 Finland

Facial pain NOS

2.3

7.7

276

J20

ICD-10 Finland

Acute bronchitis

1.5

7.7

285

1987

D07AC13

ATC

mometasone; topical

1.3

7.6

886

7380

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.6

7.6

213

1397

N04BC09

ATC

rotigotine; transdermal

4.7

7.6

R95

ICPC

Chron obstructive pulmonary disease

1.9

7.6

515

SPAT1244

SPAT

Occupational therapy

2.9

7.6

153

SAA04

NOMESCO Finland

Special inverstigation of mouth

1.6

7.6

170

1054

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

1.7

7.6

141

829

G21.8

ICD-10 Finland

Other secondary parkinsonism

8.0

7.6

G90.3

ICD-10 Finland

Multi-system degeneration

11.8

7.6

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.7

7.6

146

868

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

1.9

7.6

107

575

N06AB05

ATC

paroxetine; oral

1.7

7.6

153

923

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.8

7.6

135

782

NHL14

NOMESCO Finland

Shortening or lengthening of achilles tendon

4.5

7.5

K03.66

ICD-10 Finland

Tooth plaque

1.6

7.5

198

1278

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.6

7.5

201

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.1

7.5

406

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.5

7.5

266

1839

SXC02

NOMESCO Finland

Other oral or dental procedure, restricted

2.1

7.5

419

Z01.7

ICD-10 Finland

Laboratory examination

1.4

7.5

331

2391

PG1ST

NOMESCO Finland

Endovascular arterial thrombolysis with radiological guidance not elsewhere classified

7.1

7.5

G54.9

ICD-10 Finland

Nerve root and plexus disorder, unspecified

7.1

7.5

R06.4

ICD-10 Finland

Hyperventilation

2.7

7.5

186

M01AG02

ATC

tolfenamic acid; oral, rectal

1.4

7.5

371

2734

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

1.5

7.4

255

1748

A48

ICPC

General and Unspecified, Clarification/discussion RFE/demand

1.7

7.4

150

904

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

2.6

7.4

193

M01AH02

ATC

rofecoxib; oral

1.4

7.4

423

3191

S72.1

ICD-10 Finland

Pertrochanteric fracture

2.1

7.4

374

280

Kela drug reimbursment

Clopidogrel

2.2

7.4

307

Z73.6

ICD-10 Finland

Limitation of activities due to disability

3.0

7.4

129

S16

ICPC

Bruise/contusion

1.8

7.4

110

602

XA400

NOMESCO Finland

EEG

4.2

7.4

C08CA05

ATC

nifedipine; systemic

1.5

7.4

228

1529

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.3

7.4

269

R1410

NOMESCO Finland

Drawing up a rehabilitation plan

4.5

7.4

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.3

7.4

710

5778

C09AA02

ATC

enalapril; systemic

1.3

7.3

724

5907

I70.8

ICD-10 Finland

Atherosclerosis of other arteries

3.8

7.3

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

1.8

7.3

122

693

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

2.8

7.3

159

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

1.9

7.3

103

554

H81.3

ICD-10 Finland

Other peripheral vertigo

2.0

7.3

445

G04CA01

ATC

alfuzosin; oral

1.4

7.3

435

3307

G61.9

ICD-10 Finland

Inflammatory polyneuropathy, unspecified

10.9

7.3

M60.9

ICD-10 Finland

Myositis, unspecified

4.1

7.3

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

4.9

7.3

ZX120

NOMESCO Finland

Intravenous

1.4

7.2

302

2154

N31.1

ICD-10 Finland

Reflex neuropathic bladder, not elsewhere classified

3.6

7.2

K01

ICPC

Heart pain

2.5

7.2

219

D02

ICPC

Abdominal pain epigastric

1.6

7.2

161

995

Z71

ICD-10 Finland

Persons encountering health services for other counselling and medical advice, not elsewhere classified

2.0

7.2

435

PG1UT

NOMESCO Finland

Percutaneous aspiration throbectomy

5.1

7.2

F45.0

ICD-10 Finland

Somatization disorder

6.2

7.2

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.0

7.2

449

I63.8

ICD-10 Finland

Other cerebral infarction

3.1

7.2

115

B01AC07

ATC

dipyridamole; systemic

1.6

7.2

177

1123

D07AC01

ATC

betamethasone; topical

1.2

7.2

1093

9374

M96.0

ICD-10 Finland

Pseudarthrosis after fusion or arthrodesis

5.8

7.2

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

3.0

7.2

132

N05AF01

ATC

flupentixol; systemic

2.4

7.2

228

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

2.2

7.2

319

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.6

7.2

167

1045

N05AL01

ATC

sulpiride; systemic

2.6

7.2

195

F32.01

ICD-10 Finland

Mild depressive episode with somatic syndrome

3.7

7.1

G81.1

ICD-10 Finland

Spastic hemiplegia

20.0

7.1

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.8

7.1

111

617

L95

ICPC

Osteoporosis

1.9

7.1

499

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.3

7.1

801

6643

R07.0

ICD-10 Finland

Pain in throat

1.7

7.1

150

915

F29

ICPC

Eye symptom/complaint other

1.5

7.1

251

1733

G23.1

ICD-10 Finland

Progressive supranuclear ophthalmoplegia [Steele-Richardson-Olszewski]

7.9

7.1

L30.0

ICD-10 Finland

Nummular dermatitis

1.8

7.1

111

619

L18

ICPC

Muscle pain

1.8

7.1

111

619

C07AB02

ATC

metoprolol; systemic

1.3

7.1

775

6402

N05CD02

ATC

nitrazepam; oral

2.3

7.1

272

WX730

NOMESCO Finland

Conventional respirator

2.3

7.1

272

IBZ07

NOMESCO Finland

Neurological assessment in psychiatry

12.0

7.1

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

2.5

7.1

198

D17

ICPC

Incontinence of bowel

3.2

7.1

106

PDP20

NOMESCO Finland

Percutaneous plastic repair of common iliac artery

5.6

7.0

A04AA02

ATC

granisetron; systemic, transdermal

0.5

7.0

1196

PG1AT

NOMESCO Finland

PTA of artery not elsewhere classified

8.8

7.0

SPAT1298

SPAT

Other function in accordance with nutritional therapy nomenclature

3.1

7.0

112

G55.1*M51.1

ICD-10 Finland

Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions

2.2

7.0

316

I71.4

ICD-10 Finland

Abdominal aortic aneurysm, without mention of rupture

1.9

7.0

104

567

SPAT1285

SPAT

Provision of consultation response

1.6

7.0

178

1141

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.3

7.0

614

4937

G95.8

ICD-10 Finland

Other specified diseases of spinal cord

7.0

N06AB08

ATC

fluvoxamine; oral

2.0

7.0

391

A10BJ02

ATC

liraglutide; parenteral

2.1

7.0

343

L01BC06

ATC

capecitabine; oral

0.4

6.9

701

J01FA10

ATC

azithromycin; systemic

1.2

6.9

1711

15376

PD5BD

NOMESCO Finland

Extensive CT of aorta

2.0

6.9

406

I80.29

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

1.9

6.9

529

S76

ICPC

Skin infection other

1.6

6.9

163

1026

SPAT1139

SPAT

Nutrition survey

1.8

6.9

109

607

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

2.0

6.9

448

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

0.5

6.9

830

C02AC05

ATC

moxonidine; oral

1.6

6.9

153

948

G83.1

ICD-10 Finland

Monoplegia of lower limb

7.5

6.9

G60.0

ICD-10 Finland

Hereditary motor and sensory neuropathy

7.5

6.9

C01CA24

ATC

epinephrine; parenteral

1.7

6.9

149

915

SPF00

NOMESCO Finland

Repatation of teeth prosthesis

1.9

6.9

101

551

J31.0

ICD-10 Finland

Chronic rhinitis

1.5

6.8

201

1333

U01

ICPC

Dysuria/painful urination

1.5

6.8

207

1382

T93

ICPC

Lipid disorder

1.6

6.8

170

1082

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

2.2

6.8

293

F21

ICPC

3.1

6.8

109

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

1.8

6.8

103

568

G25.2

ICD-10 Finland

Other specified forms of tremor

4.4

6.8

RS230

NOMESCO Finland

4.4

6.8

JDB10

NOMESCO Finland

Percutaneous gastrostomy

2.4

6.8

215

P16

ICPC

Acute alcohol abuse

2.6

6.8

172

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

2.2

6.8

306

F45.9

ICD-10 Finland

Somatoform disorder, unspecified

8.3

6.8

A02BA04

ATC

nizatidine; systemic

1.5

6.8

256

1793

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

2.2

6.8

294

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.7

6.8

130

772

G12.9

ICD-10 Finland

Spinal muscular atrophy, unspecified

10.9

6.8

A28

ICD-10 Finland

Other zoonotic bacterial diseases, not elsewhere classified

10.9

6.8

R51

NOMESCO Finland

Aids services

9.3

6.8

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

3.5

6.8

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

2.7

6.8

166

I65.3

ICD-10 Finland

Occlusion and stenosis of multiple and bilateral precerebral arteries

5.6

6.7

N81

ICPC

Injury nervous system other

5.6

6.7

F71.0

ICD-10 Finland

Moderate mental retardation, with the statement of no, or minimal, impairment of behaviour

16.7

6.7

H26.4

ICD-10 Finland

After-cataract

1.4

6.7

321

2351

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.1

6.7

343

K02.2

ICD-10 Finland

Caries of cementum

1.7

6.7

133

798

XX9XW

NOMESCO Finland

3.2

6.7

105

WX306

NOMESCO Finland

Lumbar epidural anesthesy

1.6

6.7

149

922

PFQ26

NOMESCO Finland

Insertion of endovascular graft into popliteal artery

22.5

6.7

N05CD08

ATC

midazolam; nasal, systemic

2.0

6.7

372

TKC10

NOMESCO Finland

Percutaneous puncture of bladder

2.3

6.7

238

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

2.2

6.7

303

A13

ICPC

Concern/fear medical treatment

2.4

6.6

231

G40

ICD-10 Finland

Epilepsy

3.3

6.6

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

4.4

6.6

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.3

6.6

466

3634

F10.24

ICD-10 Finland

Alcohol depence active use

2.7

6.6

152

F06.9

ICD-10 Finland

Unspecified mental disorder due to brain damage and dysfunction and to physical disease

5.9

6.6

NGA20

NOMESCO Finland

Exploration of soft tissue knee or lower leg, open

5.5

6.6

M04AA01

ATC

allopurinol; systemic

1.3

6.6

484

3795

TK800

NOMESCO Finland

Hemodialysis

2.0

6.6

379

SPAT1101

SPAT

Orthostatic test

1.6

6.6

156

983

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

2.4

6.6

214

H53.9

ICD-10 Finland

Visual disturbance, unspecified

1.9

6.6

474

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.2

6.6

883

7468

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

3.7

6.5

P01BA02

ATC

hydroxychloroquine; oral

1.5

6.5

224

1537

N07XX02

ATC

riluzole; oral

8.7

6.5

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.7

6.5

136

827

N06DA02

ATC

donepezil; oral

1.5

6.5

193

1283

L48

ICPC

Musculoskeletal, Clarification/discussion RFE/demand

2.9

6.5

134

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

2.9

6.5

134

K99

ICPC

Cardiovascular disease other

1.8

6.5

102

567

NA3SA

NOMESCO Finland

Lumbar spine X-ray examination in standing position

3.2

6.5

102

N04BD01

ATC

selegiline; oral

2.4

6.5

227

R03BA02

ATC

budesonide; inhalant

1.3

6.5

513

4064

S82.6

ICD-10 Finland

Fracture of lateral malleolus

1.6

6.5

171

1106

PA6AG

NOMESCO Finland

Limited MRI examination of neck vasculature with high intensity magnet

4.1

6.5

F41.1

ICD-10 Finland

Generalized anxiety disorder

1.9

6.5

496

Z50.5

ICD-10 Finland

Speech therapy

2.4

6.5

209

C10AB05

ATC

fenofibrate; oral

2.2

6.5

292

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

3.3

6.4

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

2.3

6.4

229

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

3.1

6.4

103

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

2.6

6.4

173

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

2.0

6.4

350

F03

ICPC

Eye discharge

1.6

6.4

164

1052

A03FA01

ATC

metoclopramide; systemic, rectal

1.3

6.4

619

5034

C09DA01

ATC

losartan and diuretics; oral

1.4

6.4

339

2528

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.3

6.4

536

4281

SGB10

NOMESCO Finland

Fiiling of rooth of tooth with one root channel

1.4

6.4

328

2430

PFH58

NOMESCO Finland

Bypass from femoral or popliteal artery to proximal anterior tibial artery

7.4

6.4

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

2.4

6.4

222

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.5

6.4

225

1553

NA7DM

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with 3 Tesla magnet

14.3

6.4

G12.8

ICD-10 Finland

Other spinal muscular atrophies and related syndromes

14.3

6.4

B02.9

ICD-10 Finland

Zoster without complication

1.6

6.4

170

1104

G45.0

ICD-10 Finland

Vertebro-basilar artery syndrome

1.8

6.4

520

P74

ICPC

Anxiety disorder/anxiety state

2.0

6.4

379

KA1AE

NOMESCO Finland

Kidney ultrasound examination

1.9

6.4

476

G45.8

ICD-10 Finland

Other transient cerebral ischaemic attacks and related syndromes

3.5

6.4

K55.0

ICD-10 Finland

Acute vascular disorders of intestine

3.1

6.4

104

A07AA09

ATC

vancomycin; oral

2.5

6.4

186

F17.20

ICD-10 Finland

Addiction relationship caused by tobacco addiction relationship currently independent

3.7

6.4

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.6

6.3

139

856

RT150

NOMESCO Finland

4.9

6.3

F05

ICPC

Visual disturbance other

1.9

6.3

480

C10AA03

ATC

pravastatin; oral

1.4

6.3

254

1804

G93.3

ICD-10 Finland

Postviral fatigue syndrome

6.5

6.3

I95.9

ICD-10 Finland

Hypotension, unspecified

2.2

6.3

256

XCK00

NOMESCO Finland

Perimetry

1.5

6.3

214

1470

C08DA01

ATC

verapamil; systemic

1.7

6.3

132

806

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.4

6.3

281

2035

P85

ICPC

Mental retardation

11.0

6.3

Q79.6

ICD-10 Finland

Ehlers-Danlos syndrome

11.0

6.3

J37.0

ICD-10 Finland

Chronic laryngitis

1.8

6.3

545

SPAT1294

SPAT

Other function in accordance with health social work nomenclature

1.9

6.3

439

H02AA02

ATC

fludrocortisone; oral

3.1

6.3

105

D07XC01

ATC

betamethasone, combinations; topical

1.4

6.3

355

2678

G96.9

ICD-10 Finland

Disorder of central nervous system, unspecified

18.0

6.3

I69.1

ICD-10 Finland

Sequelae of intracerebral haemorrhage

2.5

6.3

181

UJD02

NOMESCO Finland

Gastroscopy

1.6

6.2

153

975

Z00.0

ICD-10 Finland

General medical examination

1.3

6.2

551

4429

F20.9

ICD-10 Finland

Schizophrenia, unspecified

2.3

6.2

219

A10AA01

ATC

2.0

6.2

366

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.5

6.2

180

1191

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.4

6.2

241

1698

WX704

NOMESCO Finland

Intubation

1.5

6.2

211

1447

S92.3

ICD-10 Finland

Fracture of metatarsal bone

1.9

6.2

448

G30.8

ICD-10 Finland

Other Alzheimer disease

2.0

6.2

381

OAA67

SPAT

0.5

6.2

870

FN1BT

NOMESCO Finland

Extensive endovascular dilatation of coronary (PTCA) arteries

1.9

6.2

478

CJB10

NOMESCO Finland

Laser discission of secondary cataract

1.4

6.2

282

2050

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

2.7

6.2

150

157

Kela drug reimbursment

Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)

3.9

6.2

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

3.1

6.2

101

G83.9

ICD-10 Finland

Paralytic syndrome, unspecified

6.3

6.2

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

1.8

6.1

512

M50.3

ICD-10 Finland

Other cervical disc degeneration

2.1

6.1

309

RS220

NOMESCO Finland

2.5

6.1

177

H50.52

ICD-10 Finland

Exophoria

2.8

6.1

129

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

1.5

6.1

213

1471

E66.01

ICD-10 Finland

Obesity due to excess calories

1.5

6.1

176

1165

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

2.0

6.1

336

S82.0

ICD-10 Finland

Fracture of patella

2.2

6.1

267

9694A

ICD-9 Finland

Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers

3.5

6.1

R4150

NOMESCO Finland

Neuropsychological rehabilitation

3.8

6.1

B34.9

ICD-10 Finland

Viral infection, unspecified

2.0

6.1

388

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

1.7

6.1

116

690

A06AC51

ATC

ispaghula, combinations; systemic

1.6

6.1

141

885

G62

ICD-10 Finland

Other polyneuropathies

8.6

6.0

F70.1

ICD-10 Finland

Mild mental retardation, Significant impairment of behaviour requiring attention or treatment

8.6

6.0

P70

ICPC

Dementia

2.0

6.0

378

I74.3

ICD-10 Finland

Embolism and thrombosis of arteries of lower extremities

2.4

6.0

186

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.6

6.0

154

992

PG2YT

NOMESCO Finland

Implantation of arterial endoprothesis not elsewhere classified

4.9

6.0

F01.9

ICD-10 Finland

Vascular dementia, unspecified

2.3

6.0

217

N18.8

ICD-10 Finland

Other chronic renal failure

1.8

6.0

100

571

177

Kela drug reimbursment

Insulin glargine 300 U / ml

2.1

6.0

316

PDH55

NOMESCO Finland

Bypass from iliac to femoral artery

10.0

6.0

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

1.7

6.0

107

624

K05.30

ICD-10 Finland

Periodontitis complex

1.3

6.0

361

2748

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

460

627

8.04

323.01

1.6

12.66

28.97

e6/l

0.78

369

465

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

459

627

8.02

321.73

1.7

1.6

5708.75

865.92

e6/l

0.53

377

493

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

518

742

7.74

307.65

1.5

1.4

523.76

548.03

mg/l

0.23

499

697

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2407

11663

3.24

307.65

2.8

2.1

221.28

223.61

u/l

0.03

2279

10852

(3044290) Cell count panel - Cerebral spinal fluid

428

608

7.66

289.33

1.5

1.6

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

437

665

7.16

277.35

1.4

3.77

3.83

mmol/l

0.51

407

617

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

621

1390

5.01

262.31

2.7

2.2

290.50

687.62

ug/l

1.83

586

1317

(3033658) Prothrombin time (PT) actual/Normal

1952

9829

2.72

227.12

5.7

4.2

86.84

86.08

0.61

1900

9607

(3018418) pH of Serum or Plasma

2135

11686

2.55

203.38

4.5

4.1

7.40

0.22

322

2143

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2882

18296

2.55

196.95

7.5

6.3

1.21

mmol/l

2.55

2655

16465

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

203

181

11.69

195.23

1.2

1.1

47.92

44.88

mg/l

0.20

155

153

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

192

166

12.03

188.33

1.1

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

2725

17123

2.46

186.22

5.2

5.0

34.40

34.91

g/l

4.34

2544

15810

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

3029

20030

2.51

183.79

8.1

7.1

1.21

mmol/l

1.93

2602

16902

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

192

173

11.54

183.30

1.1

311.68

291.03

mg/l

0.36

158

151

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2646

16525

2.42

181.57

2.5

2.0

92.80

93.74

pmol/l

0.47

1458

8559

(3030467) Casts [#/volume] in Urine by Automated count

2000

11225

2.39

172.62

4.2

3.3

0.55

0.49

e6/l

0.46

1533

8523

(36304419) Bacteria [Presence] in Urine

1940

10823

2.37

168.82

4.2

3.3

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

207

245

8.80

162.01

1.1

—

(3002582) Erythrocytes [#/volume] in Urine

2080

12217

2.28

157.40

4.3

3.4

51.03

99.92

e6/l

1.53

1607

9453

(4027681)

154

126

12.61

156.24

1.4

1.2

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1316

6385

2.49

153.99

2.7

2.2

30.33

30.06

0.84

1288

6191

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

172

175

10.17

150.86

1.1

0.42

9.36

nmol/l

2.15

(3018095) Leukocytes [#/volume] in Urine

2264

14001

2.22

148.30

5.1

3.9

124.18

119.26

e6/l

0.05

1665

10076

(3032080) INR in Blood by Coagulation assay

2562

16677

2.21

147.15

10.6

10.3

1.24

1.33

inr

4.65

636

4480

(3020630) Protein [Mass/volume] in Serum or Plasma

871

3523

2.82

146.84

1.9

2.7

66.44

65.96

g/l

1.05

801

3180

(3021960) Folate [Moles/volume] in Serum or Plasma

1730

9665

2.27

144.76

1.7

1.6

19.48

20.25

nmol/l

1.29

1530

8140

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1373

7002

2.37

141.97

3.5

3.0

1.17

1.16

e6/l

0.01

774

4107

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1312

6562

2.40

141.78

3.7

3.2

2.50

2.07

e6/l

0.82

713

3703

(3016018) Differential panel - Cerebral spinal fluid

219

325

7.03

141.03

1.6

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

3204

23109

2.28

138.76

7.0

4.8

6.83

6.82

mmol/l

0.08

3074

21684

(3014576) Chloride [Moles/volume] in Serum or Plasma

1117

5277

2.48

136.28

8.1

6.7

104.40

104.47

mmol/l

0.20

1104

5155

(3004588) Protein electrophoresis panel - Serum or Plasma

747

2895

2.89

135.67

1.8

2.4

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

419

1137

3.95

135.22

1.9

2.4

0.00

g/l

0.50

387

1034

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

414

1115

3.98

135.02

1.9

2.4

0.00

g/l

0.00

387

1030

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

622

2203

3.11

132.51

2.5

2.4

29.94

21.47

au/ml

0.49

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

580

1978

3.21

131.73

1.4

1.3

31.91

53.60

au/ml

0.98

(3000991) Gas panel - Venous blood

861

3663

2.66

130.22

9.7

8.2

—

(3023410) Appearance of Cerebral spinal fluid

204

306

6.93

129.99

1.7

2.0

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

429

1216

3.79

129.96

1.9

2.3

0.02

0.04

g/l

0.41

396

1110

(3026008) Bacteria identified in Urine by Culture

1979

12059

2.13

129.35

3.9

3.3

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

438

1279

3.68

126.93

1.9

2.2

38.38

37.24

g/l

3.60

397

1087

(3014111) Lactate [Moles/volume] in Serum or Plasma

862

3718

2.62

126.49

8.6

6.9

1.31

1.37

mmol/l

0.85

835

3564

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

153

173

9.11

123.93

1.5

1.4

5.97

6.53

u/l

0.17

119

149

(3031040) Bacteria [#/volume] in Urine by Automated count

3355

25260

2.22

121.65

6.6

4.7

253.90

1754.06

e6/l

3.31

383

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

479

1525

3.39

121.35

1.8

2.4

3.03

3.12

g/l

1.25

405

1182

(3023368) Bacteria identified in Blood by Culture

1891

11559

2.08

120.20

5.5

4.3

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

452

1399

3.47

119.67

1.9

2.5

0.52

1.13

g/l

3.63

406

1192

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

480

1547

3.35

119.17

1.8

2.3

9.78

10.27

g/l

1.95

418

1295

(3006315) Basophils [#/volume] in Blood

2695

18848

2.04

116.69

6.2

5.8

0.04

e9/l

0.18

2260

16026

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

169

234

7.46

115.74

1.4

1.2

1.89

2.09

mmol/l

1.64

155

221

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

495

1655

3.23

115.61

1.8

2.4

—

(3001604) Monocytes [#/volume] in Blood

2681

18755

2.03

115.50

6.2

5.8

0.63

0.61

e9/l

2.69

2242

15932

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

495

1656

3.23

115.49

1.8

2.4

7.38

7.44

g/l

0.30

406

1209

(42870588) Differential panel, method unspecified - Blood

2084

13338

2.03

115.37

5.8

5.9

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

494

1652

3.23

115.32

1.8

2.4

3.73

3.83

g/l

0.76

404

1156

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

126

124

10.42

113.01

1.1

1.08

1.17

u/l

0.40

(3013115) Eosinophils [#/volume] in Blood

2740

19442

2.02

111.86

6.5

6.0

0.20

e9/l

0.12

2340

16775

(3019198) Lymphocytes [#/volume] in Blood

2712

19237

2.00

110.04

6.2

5.9

1.90

1.91

e9/l

0.06

2310

16652

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1401

7872

2.12

109.32

5.0

3.8

402.77

525.22

ng/l

0.40

1217

6593

(3022096) Basophils/100 leukocytes in Blood

2486

17242

1.96

106.12

6.4

6.1

0.64

0.66

1.73

2352

15991

(3006504) Eosinophils/100 leukocytes in Blood

2532

17726

1.96

104.51

6.4

6.1

2.73

2.87

2.47

2390

16416

(3019069) Monocytes/100 leukocytes in Blood

2540

17817

1.95

104.05

6.6

6.4

8.82

0.01

2394

16565

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

952

4668

2.31

103.56

1.9

1.8

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

179

298

6.21

102.99

1.7

1.5

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

952

4681

2.30

102.80

1.9

1.7

—

(3019309) Folate [Moles/volume] in Red Blood Cells

1392

7959

2.07

102.51

1.9

1.8

1090.49

1160.98

nmol/l

2.12

1062

5883

(3026782) Osmolality of Urine

1403

8053

2.07

102.18

3.4

2.9

535.23

556.40

mosm/kgh2o

3.43

1204

6831

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1192

6448

2.15

101.50

3.3

3.6

0.80

0.81

mmol/l

2.73

1113

5990

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1693

10442

1.98

100.41

2.5

2.3

2.89

3.02

mg/l

1.22

1448

8838

(3013707) Erythrocyte sedimentation rate by Westergren method

3486

27472

2.12

100.21

4.8

4.1

14.85

13.40

mm/h

5.69

3233

25138

(3013650) Neutrophils [#/volume] in Blood by Automated count

2946

21890

1.97

99.87

9.0

8.9

4.54

4.21

e9/l

8.28

2511

18904

(3002030) Lymphocytes/100 leukocytes in Blood

2566

18211

1.93

99.81

6.6

6.2

25.50

27.19

11.81

2410

16811

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

569

2230

2.77

99.44

5.9

4.8

24.02

24.03

mmol/l

0.02

536

2016

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

573

2260

2.75

98.89

9.8

8.9

24.06

24.23

mmol/l

0.59

551

2095

(3022948) Iron [Moles/volume] in Serum or Plasma

1186

6484

2.12

97.70

2.8

2.6

11.39

12.64

umol/l

7.53

1090

5994

(3037467) Urinalysis macro (dipstick) panel - Urine

3346

26107

2.04

96.92

5.9

4.5

—

(3018010) Neutrophils/100 leukocytes in Blood

2526

17941

1.91

96.84

6.5

6.0

59.17

57.64

8.03

2385

16651

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2740

20048

1.91

95.14

5.7

6.3

11.84

12.41

umol/l

1.14

2601

18990

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3628

29241

2.15

95.02

8.2

7.6

82.78

81.59

u/l

0.60

3426

27376

(3000850) Epithelial cells [#/volume] in Urine

1438

8543

1.99

93.62

3.2

2.7

5.06

e6/l

0.00

1276

7447

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

767

3566

2.38

93.49

2.7

2.4

52.79

38.67

u/l

0.50

628

3028

(3044640) Blood type and Crossmatch panel - Blood

1904

12443

1.91

93.27

3.2

2.6

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

151

236

6.58

92.39

1.1

1.0

273.42

329.64

ng/l

0.43

152

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

151

237

6.55

92.02

1.1

1.0

43.96

45.61

ng/l

0.03

150

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1562

9601

1.95

91.71

2.9

2.5

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

150

236

6.54

91.19

1.1

1.0

675.36

676.13

ng/l

0.01

150

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1107

6031

2.10

91.17

2.8

2.5

2.24

2.29

g/l

1.91

1019

5564

(40758558) Short blood count panel - Blood

1579

9773

1.94

90.58

6.7

6.8

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

947

4868

2.19

90.57

7.9

6.9

5.14

5.08

kpa

1.35

907

4626

(3027801) Oxygen [Partial pressure] in Arterial blood

946

4868

2.19

90.19

7.9

6.9

12.03

12.15

kpa

0.31

905

4627

(3003396) Base excess in Arterial blood by calculation

943

4850

2.19

90.01

7.9

6.9

0.70

1.00

mmol/l

1.27

768

3750

(3015377) Calcium [Moles/volume] in Serum or Plasma

1980

13218

1.88

89.80

2.9

3.4

2.35

mmol/l

0.93

1722

11291

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1054

5667

2.12

89.70

2.9

2.6

20.82

22.40

2.95

909

4814

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2233

15489

1.86

89.61

3.5

2.9

137.05

146.10

ug/l

0.69

2061

14119

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1344

7897

1.99

89.60

2.0

1.8

1.49

1.43

mg/l

0.15

1037

6120

(3006653) Thiamine [Moles/volume] in Blood

121

154

8.04

89.02

1.1

1.2

137.59

138.00

nmol/l

0.03

121

154

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1194

6776

2.03

87.49

2.0

1.8

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1013

5430

2.11

86.53

6.0

6.2

1.06

mmol/l

0.37

952

5032

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2194

15337

1.82

83.97

2.6

2.2

76.64

78.32

nmol/l

1.91

1950

13493

(3021589) Normoblasts [#/volume] in Blood

2321

16548

1.81

82.79

11.6

10.0

0.00

e9/l

0.57

1821

13353

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1245

7369

1.95

79.67

2.9

3.1

2.46

mmol/l

0.60

1078

6417

(3021447) Carbon dioxide [Partial pressure] in Venous blood

819

4174

2.17

79.00

5.5

4.3

5.88

5.82

kpa

1.00

795

4049

(3002032) Base excess in Venous blood by calculation

816

4163

2.17

78.46

5.5

4.3

1.65

1.86

mmol/l

0.78

680

3354

(3037522) Nuclear Ab [Titer] in Serum

858

4494

2.12

76.93

1.4

1.3

618.05

521.64

titre

0.53

164

954

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1740

11586

1.81

76.05

3.4

3.3

36.27

37.47

u/l

0.14

1650

10945

(3012544) pH of Venous blood

829

4304

2.13

75.98

5.5

4.3

7.41

7.37

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2425

17902

1.75

73.28

4.5

4.2

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

696

3446

2.20

71.65

1.8

1.7

1.68

1.52

4.13

597

2954

(3007853) Bacteria identified in Skin by Aerobe culture

846

4517

2.07

71.59

2.2

1.8

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

769

3965

2.13

71.38

8.9

7.6

119.70

120.82

g/l

0.81

742

3816

(3052851) Hemolysis interference index of Serum or Plasma

338

1206

2.95

69.57

4.0

3.5

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1396

8886

1.82

69.47

4.0

3.7

—

(3024869) Neuronal Ab [Presence] in Serum

12.27

69.38

1.0

1.2

—

(3016502) Oxygen saturation in Arterial blood

816

4350

2.07

69.12

8.7

7.2

95.14

95.47

0.61

791

4183

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3876

33272

2.06

67.79

5.5

4.6

1.93

2.09

mu/l

1.71

3587

29866

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

109

168

6.62

67.55

1.8

1.6

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

279

907

3.21

67.43

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

279

907

3.21

67.43

1.4

1.3

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

4160

36750

2.41

66.93

25.3

15.8

27.31

26.20

mg/l

1.30

3637

29521

(3042936) Bacteria identified in Isolate by Culture

974

5595

1.94

66.45

2.3

2.0

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

3328

27330

1.79

65.03

4.3

3.8

14.95

14.93

pmol/l

0.21

3010

24380

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

13.08

64.82

1.1

—

(3044889) 12 lead EKG panel

3213

26168

1.76

64.03

4.9

4.1

—

(3002385) Erythrocyte distribution width [Ratio]

3554

29841

1.85

63.56

32.3

19.4

14.02

13.79

15.03

3492

29137

(3005719) IgG [Mass/volume] in Serum or Plasma

567

2716

2.24

62.83

2.5

2.8

10.27

10.45

g/l

0.43

497

2468

(3035350) Ketones [Presence] in Urine by Test strip

2399

18178

1.67

61.37

4.7

3.8

0.00

estimate

0.00

439

3268

(3007164) IgA [Mass/volume] in Serum or Plasma

1091

6685

1.83

60.08

1.5

2.45

2.53

g/l

0.64

559

3852

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1784

12599

1.68

59.18

3.1

3.2

2014.29

1689.24

ng/l

1.27

1558

10927

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1179

7438

1.79

58.71

1.3

1.60

1.86

u/ml

0.33

219

1809

(3009445) Proteinase 3 Ab [Units/volume] in Serum

395

1664

2.50

58.49

1.4

1.5

14.73

21.38

u/ml

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

862

4947

1.91

58.12

2.8

4.1

238.80

246.46

u/l

0.72

805

4645

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2809

22378

1.66

57.31

3.8

3.2

59.79

52.25

u/l

2.41

2610

20459

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

531

2573

2.20

56.92

1.9

1.7

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

708

3827

2.00

56.78

2.2

2.3

0.21

0.20

g/l

0.82

660

3555

(3021601) Nitrite [Presence] in Urine by Test strip

2382

18250

1.63

56.40

6.4

5.1

0.00

estimate

0.50

452

3324

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

130

6.80

55.52

1.5

1.1

76.57

73.27

—

(3027945) Reticulocytes/100 erythrocytes in Blood

874

5107

1.88

55.49

2.2

2.7

1.81

1.75

1.11

770

4483

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

8.16

55.48

1.2

150.10

126.68

nmol/l

0.40

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

484

2284

2.25

55.29

10.6

9.6

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

777

4378

1.93

55.10

2.9

3.0

7.46

8.98

umol/l

1.75

663

3844

(3020779) Urea [Moles/volume] in Serum or Plasma

717

3934

1.97

54.96

6.9

7.3

10.82

10.57

mmol/l

0.38

677

3731

(3009261) Glucose [Presence] in Urine by Test strip

2397

18475

1.62

54.73

4.8

3.8

0.01

0.00

estimate

0.33

440

3227

(3024354) Oxygen [Partial pressure] in Venous blood

649

3485

2.00

52.76

4.9

3.8

4.55

4.59

kpa

0.15

625

3372

(3019550) Sodium [Moles/volume] in Serum or Plasma

4222

38240

2.29

52.03

30.0

18.7

139.28

139.63

mmol/l

13.14

4145

37228

(3023103) Potassium [Moles/volume] in Serum or Plasma

4223

38315

2.27

50.76

30.3

18.9

3.98

3.99

mmol/l

0.87

4144

37241

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

317

1288

2.57

50.48

1.6

1.5

178.46

264.24

titre

0.51

(3009466) Valproate [Moles/volume] in Serum or Plasma

166

466

3.66

50.43

5.6

4.6

388.37

350.74

umol/l

2.49

149

398

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

681

3793

1.93

49.57

2.8

3.0

288.00

225.51

ng/l

1.53

616

3473

(3036481) Cortisol [Moles/volume] in Serum or Plasma

601

3239

1.98

48.07

1.9

2.3

372.07

372.16

nmol/l

0.00

557

2951

(3015171) Extractable nuclear Ab [Units/volume] in Serum

298

1215

2.55

47.07

1.2

2.06

0.85

u/ml

0.44

116

(3009542) Hematocrit [Volume Fraction] of Blood

3731

32697

1.75

46.67

30.3

17.2

38.44

39.05

3.92

2595

21751

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

334

1458

2.39

45.49

1.6

1.8

38.57

38.63

u/l

0.02

285

1240

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

574

3148

1.94

43.38

4.3

4.1

98.78

94.20

ng/l

0.46

499

2683

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

7.62

43.27

1.5

1.1

18.00

17.29

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

417

2056

2.13

42.29

1.5

1.7

1.64

1.53

g/l

1.53

375

1762

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

264

1071

2.55

42.08

1.4

15.96

12.76

iu/ml

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

341

1553

2.29

42.07

2.8

3.6

0.33

0.34

u/ml

0.13

187

890

(3036489) Thrombin time

318

1411

2.35

41.68

2.4

2.5

22.98

21.65

1.03

293

1273

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

127

5.91

41.26

1.1

563.92

416.17

ng/l

0.10

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

537

2933

1.94

40.96

1.9

1.7

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

699

4165

1.80

40.50

4.5

3.5

—

(3003338) MCHC [Mass/volume]

3450

30073

1.59

38.89

33.8

20.6

330.65

332.04

g/l

15.05

3409

29809

(40761511) CBC panel - Blood by Automated count

4124

37711

1.92

38.77

22.2

15.1

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

3778

33703

1.68

38.47

7.3

6.3

41.34

40.48

mmol/mol

5.25

3483

30702

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1599

11880

1.53

38.24

2.9

2.5

56.42

59.10

u/l

0.87

1477

10879

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

3795

33926

1.68

37.95

23.9

15.1

77.09

76.36

ml/min/173m2

1.12

3316

27983

(3024928) Oxygen saturation in Venous blood

225

888

2.61

37.92

6.1

3.6

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

174

4.84

37.15

1.1

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

4198

38719

1.98

36.92

28.5

18.7

83.23

81.20

umol/l

2.04

4198

38708

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

860

5601

1.66

35.74

1.3

42.25

38.40

iu/ml

0.18

230

1711

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

239

1002

2.46

35.49

1.6

1.5

0.24

g/l

0.01

229

948

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

185

4.61

35.44

1.1

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

243

1031

2.43

35.15

1.6

1.5

1.18

1.17

g/l

0.21

234

973

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

262

1150

2.36

35.13

3.3

3.1

3.65

3.52

g/l

0.60

250

1087

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

247

1059

2.41

34.91

2.8

2.9

197.73

198.63

0.06

230

1014

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4186

38709

1.92

34.45

13.5

10.9

25.48

25.61

u/l

0.17

4054

37070

(3051611) Lipemic interference index of Serum or Plasma

137

435

3.22

34.37

3.9

3.4

—

(3023183) Ammonium ion [Moles/volume] in Plasma

213

874

2.51

33.11

3.4

2.6

32.80

35.40

umol/l

0.72

182

728

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

444

2457

1.89

32.23

1.5

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

255

1152

2.28

31.96

2.7

3.3

87.60

89.38

0.51

241

1094

(3024891) Influenza virus A+B Ag [Presence] in Specimen

219

929

2.43

31.68

1.2

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1906

15118

1.45

30.99

5.0

3.9

35.59

51.93

ng/l

3.02

1461

11231

(36660697) Celiac disease serology panel - Serum

478

2742

1.83

30.93

1.2

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1365

10178

1.49

30.47

3.0

2.9

1841.95

5373.58

umol/l

4.74

1147

8686

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

595

3717

1.69

28.47

2.5

2.3

6.15

7.09

ug/l

0.91

522

3189

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

5.52

27.68

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

5.52

27.68

1.1

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2397

20085

1.40

27.34

2.9

2.7

—

(3009508) Creatinine [Moles/volume] in Urine

1612

12605

1.43

27.33

3.6

3.2

7.17

7.43

mmol/l

1.36

1348

10447

(46235355) HIV 1 and 2 tests - Meaningful Use set

725

4812

1.60

27.20

1.7

—

(3023520) Reticulocytes [#/volume] in Blood

611

3887

1.66

27.20

2.2

2.7

69.97

68.09

e9/l

0.59

394

2933

(3007461) Platelets [#/volume] in Blood

4278

40276

1.91

26.98

36.1

23.3

247.49

244.43

e9/l

2.23

4176

39078

(3024731) MCV [Entitic volume]

4278

40284

1.91

26.84

36.0

23.2

91.72

91.29

7.10

4219

39587

(3037756) Immunofixation for Serum or Plasma

209

935

2.29

26.80

1.3

1.6

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

100

5.35

26.79

1.1

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

272

1353

2.07

26.73

2.4

3.4

2.06

4.13

ratio

0.65

(3010813) Leukocytes [#/volume] in Blood

4278

40292

1.91

26.70

36.1

23.3

7.29

6.84

e9/l

24.66

4164

38936

(3035941) MCH [Entitic mass]

4277

40284

1.90

26.63

36.0

23.2

30.39

30.36

0.35

4218

39586

(3000963) Hemoglobin [Mass/volume] in Blood

4278

40298

1.90

26.60

36.4

23.4

130.63

134.03

g/l

39.26

4219

39604

(3026361) Erythrocytes [#/volume] in Blood

4277

40286

1.90

26.59

36.1

23.3

4.34

4.44

e12/l

28.56

4159

38937

(3012516) Albumin [Mass/volume] in Urine

1547

12053

1.43

26.57

3.6

3.3

860.56

321.31

mg/l

2.64

1091

7702

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

101

5.30

26.50

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

11.80

26.49

1.1

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

276

1388

2.05

26.33

2.4

3.4

70.06

104.80

mg/l

0.36

232

1143

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

5.54

26.28

1.1

—

(40768797) Stomach Pathology biopsy report

758

5127

1.57

26.15

1.4

1.3

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

5.48

25.97

1.0

1.1

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

274

1386

2.04

25.72

2.4

3.4

37.01

60.02

mg/l

1.43

228

1142

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

153

613

2.55

25.04

1.2

35.75

47.28

u/ml

0.38

(3028026) IgM [Mass/volume] in Serum or Plasma

381

2175

1.82

24.88

1.8

1.9

1.23

1.35

g/l

0.75

339

1967

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

350

1957

1.85

24.43

4.9

3.0

0.66

0.65

0.11

337

1872

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

5.94

24.30

1.0

1.4

—

(3000492) Spirometry study

504

3142

1.68

24.11

1.5

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

233

1138

2.10

24.03

1.7

—

(1616796) Gas panel - Central venous blood

205

956

2.20

23.79

3.6

4.2

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

109

377

2.94

23.69

1.2

20.97

49.58

u/ml

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

15.06

23.64

1.3

1.2

28.22

33.13

—

(3022217) INR in Platelet poor plasma by Coagulation assay

825

5806

1.51

23.52

26.9

28.4

1.52

1.46

inr

0.33

751

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1131

8504

1.44

22.95

1.9

1.7

13166922.31

28187763.33

pmol/l

0.52

919

6918

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

196

912

2.20

22.88

1.3

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

7.13

22.87

1.2

1.1

41.22

57.88

—

(3019060) Gas panel - Arterial blood

454

2805

1.69

22.40

4.1

4.6

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

126

4.41

22.18

1.1

1.0

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1584

12712

1.38

21.75

4.4

4.0

14.22

10.65

mg/mmol

1.08

1061

8089

(3051651) Icteric interference index of Serum or Plasma

251

3.27

21.26

4.0

3.5

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

285

3.09

20.83

1.2

72.11

175.63

titre

1.56

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

7.67

20.80

1.1

1.0

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3812

35320

1.47

20.33

5.3

4.9

6.23

6.03

mmol/l

11.67

3433

31612

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

243

3.21

19.64

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

243

3.21

19.64

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

243

3.21

19.64

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

245

3.18

19.38

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

245

3.18

19.38

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

246

3.17

19.25

1.1

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

200

1006

2.03

19.09

1.7

1.6

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

524

3486

1.57

19.05

1.6

1.5

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

7.33

18.64

1.1

1.0

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

238

1283

1.90

18.59

1.3

—

(3012501) Base excess in Blood by calculation

186

922

2.06

18.48

4.4

4.8

2.57

2.75

mmol/l

0.44

137

623

(3004119) Hemoglobin [Mass/volume] in Venous blood

411

2606

1.63

18.24

5.4

3.6

126.85

127.81

g/l

0.39

401

2539

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

180

893

2.06

17.85

1.3

1.2

20.66

47.85

u/ml

1.02

(3028717) Thiamine [Mass/volume] in Blood

7.26

17.79

1.1

1.3

—

(3003181) Sodium [Moles/volume] in Urine

154

722

2.17

17.70

1.4

62.61

64.24

mmol/l

0.21

132

586

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

10.04

17.59

1.0

—

(3014051) Protein [Presence] in Urine by Test strip

184

927

2.03

17.50

2.5

2.3

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

7.39

17.37

2.4

1.5

—

(3000494) Fungus identified in Specimen by Culture

616

4325

1.49

17.35

1.5

1.4

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

732

5320

1.45

17.26

1.3

1.2

22.02

13.41

u/ml

0.37

227

1895

(3000570) Elastase.pancreatic [Mass/mass] in Stool

210

1114

1.93

17.23

1.5

1.4

283.94

272.46

ug/g

0.39

146

667

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

182

924

2.01

16.95

1.4

1.5

—

(40767503) Oxygen content in Capillary blood by calculation

179

908

2.01

16.72

2.7

2.6

16.27

16.13

0.17

485

(40760888) Immunoglobulin light chains.free panel - Serum

198

1046

1.93

16.46

2.1

3.5

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

110

465

2.40

16.16

1.3

1.2

3.56

5.11

u/ml

0.80

201

(4010399)

405

2635

1.59

16.13

1.4

—

(3010421) pH of Blood

201

1076

1.91

16.06

4.3

4.5

7.42

0.11

182

905

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

221

3.06

15.94

1.2

32.72

21.45

u/l

0.68

189

(3048689) Calprotectin [Mass/mass] in Stool

568

3991

1.48

15.86

2.1

2.3

153.39

150.59

ug/g

0.05

442

3112

(1761868) Lipid panel - Serum or Plasma

858

11050

0.73

15.51

3.4

3.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

150

3.49

15.35

1.2

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

12.54

15.14

1.1

1.3

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

311

1927

1.66

15.09

2.9

3.2

4.30

4.45

pmol/l

1.59

274

1684

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

377

2.50

14.99

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

4.47

14.92

1.2

1.1

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

129

605

2.16

14.87

1.6

1.3

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

141

685

2.09

14.84

1.2

2.90

7.07

u/ml

0.54

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

190

1028

1.88

14.72

1.1

1.2

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

232

2.92

14.67

1.2

122.79

86.91

u/l

0.75

202

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

240

2.86

14.39

1.5

2.0

—

(3003694) ABO and Rh group [Type] in Blood

1215

9842

1.32

14.33

1.4

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

190

1038

1.87

14.29

1.1

1.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

122

569

2.18

14.27

1.3

—

(42529406) Shigella sp [Presence] in Stool by Culture

190

1044

1.86

14.04

1.1

1.2

—

(3002619) Bacteria identified in Specimen by Culture

4.60

13.74

1.3

1.1

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

158

830

1.94

13.41

1.3

1.2

4.46

7.68

u/ml

0.30

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

429

2.31

13.37

1.3

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

159

840

1.92

13.27

1.3

1.2

11.31

8.27

u/ml

0.16

123

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

105

478

2.22

13.07

1.3

1.2

1.71

4.10

u/ml

1.89

163

(3034426) Prothrombin time (PT)

3.86

13.04

1.1

1.3

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

148

3.27

12.83

2.5

2.6

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

159

850

1.90

12.82

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

110

3.66

12.72

1.1

1835.20

1524.90

miu/ml

0.73

110

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

461

3248

1.47

12.60

3.9

1.22

1.23

mmol/l

0.73

391

2828

(3021879) Hepatitis B virus core Ab [Presence] in Serum

337

2225

1.56

12.56

1.4

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

565

4138

1.42

12.52

1.6

—

(4268621)

319

2.47

12.41

2.4

2.3

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3818

36097

1.34

12.16

5.8

5.2

2.43

2.63

mmol/l

35.57

3474

32656

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

435

2.23

12.12

3.1

3.6

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

185

2.94

12.11

1.1

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

102

475

2.17

12.04

1.3

0.16

0.34

nmol/l

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

162

893

1.84

11.90

1.6

1.5

25.67

27.22

iu/l

0.22

124

719

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

3597

33755

1.30

11.86

4.4

4.1

1.37

1.28

mmol/l

10.16

3234

30206

(3022621) pH of Urine by Test strip

375

2567

1.50

11.82

3.7

3.2

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1186

9784

1.29

11.80

1.7

1.6

1.40

1.33

mmol/l

2.03

1018

8153

(21494890) Protein electrophoresis panel - 24 hour Urine

447

2.20

11.76

1.6

2.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

451

2.18

11.51

1.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

321

2145

1.53

11.34

2.5

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

3732

35252

1.31

11.34

5.0

4.6

4.25

4.51

mmol/l

41.22

3402

32095

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

5.39

11.34

1.0

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

100

3.62

11.32

1.0

1.1

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

245

2.59

11.16

1.3

1.2

1.49

1.15

promille

0.87

189

(40768804) Tissue Pathology biopsy report

1719

14906

1.24

11.05

2.2

—

(3029937) Albumin [Presence] in Urine by Test strip

1188

9883

1.27

10.90

5.6

4.2

0.00

estimate

1.28

433

3147

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

112

563

2.01

10.85

5.0

6.6

12.00

12.11

mg/l

0.09

101

515

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

170

2.90

10.79

1.1

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

336

2.31

10.67

1.1

1.2

93.51

94.53

0.11

316

(3016650) Hepatitis A virus Ab [Presence] in Serum

106

527

2.04

10.60

1.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

117

609

1.95

10.29

1.2

—

(3020961) Endomysium IgA Ab [Titer] in Serum

242

1557

1.59

10.12

1.2

1.1

21.67

187.53

titre

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

375

2648

1.45

10.11

6.0

6.6

24.88

24.49

mmol/l

1.02

347

2469

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

437

2.10

10.00

1.3

1.4

283.52

275.97

pmol/l

0.09

332

(3011648) Oxygen content in Venous blood

340

2.26

9.96

7.0

4.0

10.17

10.97

0.92

340

(3049717) Cytology report of Urine Cyto stain

268

1774

1.54

9.90

2.7

2.8

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

185

1120

1.68

9.88

5.1

5.8

1.63

1.59

mg/l

0.31

171

1018

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

433

2.10

9.85

1.1

122.78

114.80

0.98

390

(3028626) Oxygen [Partial pressure] in Capillary blood

202

1254

1.64

9.80

3.7

5.0

8.53

8.40

kpa

0.41

190

1174

(3011412) CD3 cells [#/volume] in Blood

350

2.22

9.72

2.7

2.3

1.30

1.19

e9/l

0.45

215

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

389

2.15

9.72

1.2

108.73

71.67

u/l

0.32

258

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3685

34933

1.28

9.64

4.9

4.6

1.36

1.44

mmol/l

23.81

3340

31542

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

5.30

9.63

1.0

1.2

—

(4306422)

439

2.07

9.51

1.2

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

266

1775

1.53

9.48

2.2

1.9

3.72

2.19

ug/l

0.43

228

1534

(3009214) Lutropin [Units/volume] in Serum or Plasma

140

795

1.78

9.41

1.6

1.5

11.00

9.27

u/l

0.72

107

616

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1589

13837

1.23

9.40

5.4

4.1

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

103

530

1.97

9.40

1.5

1.6

0.69

0.88

g/l

1.24

413

(3023420) DNA double strand Ab [Units/volume] in Serum

350

2.19

9.31

1.7

1.3

—

27.69

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

274

2.35

9.31

2.6

2.3

14.00

12.09

0.60

145

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

7.02

9.28

1.1

1.0

—

(3002256) Pathology report gross observation

646

5066

1.32

9.16

1.3

—

(3045414) Leukocytes [Presence] in Urine

260

1740

1.52

9.15

2.2

2.0

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

4.28

9.11

1.0

1.2

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

259

2.37

9.05

2.9

2.3

514.22

508.26

e6/l

0.03

217

(21494755) Public health laboratory ask at order entry panel

112

1996

0.55

9.04

1.4

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

165

2.74

9.01

1.1

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

163

980

1.69

8.97

2.3

130.42

128.73

g/l

0.36

123

701

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

5.50

8.96

1.1

1.0

—

(3029075) Extractable nuclear Ab panel - Serum

3.39

8.88

1.0

1.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

268

2.33

8.84

2.6

2.4

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

107

570

1.90

8.84

1.2

1.1

15.56

97.29

iu/ml

2.35

125

(3028707) Methadone [Presence] in Urine by Screen method

358

2.14

8.82

4.1

2.1

—

(40761536) Microorganisms panel - Urine sediment

426

3153

1.39

8.81

6.2

4.0

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

146

856

1.73

8.81

1.4

1.3

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

4.12

8.70

1.0

1.2

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

240

2.39

8.63

1.5

1.7

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

240

2.39

8.63

1.5

1.7

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

413

3064

1.38

8.42

3.5

2.8

62.55

62.04

ml/min/173m2

0.09

164

1273

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

249

2.35

8.42

2.9

2.4

0.21

e9/l

0.03

216

(3011985) Renin [Units/volume] in Plasma

476

1.95

8.31

1.4

84.28

61.40

mu/l

0.41

420

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

415

2.02

8.26

1.3

—

nmol/l

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

138

812

1.72

8.25

1.7

1.6

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

191

2.53

8.21

1.1

1.2

2.80

4.56

iu/ml

—

(3045788) Cell count panel - Pleural fluid

452

1.97

8.13

1.4

1.5

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

110

609

1.83

8.09

1.3

—

(4035726)

458

3479

1.35

8.05

1.3

1.4

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

371

4961

0.73

7.93

4.7

33.25

33.01

0.15

256

3220

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

226

2.36

7.84

2.8

2.0

201.20

235.48

ug/min

—

(3019150) Specific gravity of Urine by Refractometry

963

8082

1.24

7.82

5.1

4.2

1.02

kg/l

0.18

188

1263

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

280

1972

1.45

7.69

1.2

116.96

143.47

iu/ml

0.48

693

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

102

562

1.83

7.64

1.0

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1031

8738

1.23

7.62

3.0

3.2

0.74

0.82

ug/l

1.25

773

6224

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

218

1464

1.51

7.60

2.1

2.6

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

140

2.73

7.59

1.7

2.5

107.42

156.84

umol/l

0.57

(3008295) Osmolality of Serum or Plasma

397

1.98

7.43

1.5

1.4

284.74

278.95

mosm/kgh2o

1.18

295

(3014148) Varicella zoster virus Ab [Titer] in Serum

336

2.07

7.42

1.2

—

(3022145) Colonoscopy Study observation

524

4110

1.31

7.37

1.4

1.3

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

3.10

7.27

1.4

1.3

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

230

1577

1.48

7.26

1.2

1.3

—

(3007566) Smooth muscle Ab [Titer] in Serum

153

958

1.62

7.26

1.3

1.2

149.17

86.12

titre

0.62

(3018405) Lactate [Moles/volume] in Arterial blood

218

1480

1.50

7.23

3.6

1.52

1.41

mmol/l

0.56

211

1458

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

20.04

7.13

1.1

1.0

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

221

1512

1.48

7.06

2.2

3.4

299.82

3543.24

u/ml

1.07

182

1298

(3023511) Choriogonadotropin [Units/volume] in Urine

336

2.04

7.05

1.5

1.3

—

(21494815) CD4 cells/100 lymphocytes in Specimen

296

2.11

7.04

2.6

2.3

45.60

43.59

—

(3020891) Body temperature

241

1682

1.46

6.97

4.1

4.4

—

(3025941) Bacteria identified in Stool by Culture

264

1875

1.43

6.95

1.4

1.3

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

4.37

6.95

2.1

2.3

23.72

19.21

umol/l

0.68

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

189

1256

1.53

6.95

1.7

1.6

—

(3012441) Differential panel - Pleural fluid

493

1.84

6.91

1.4

1.5

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

171

2.47

6.91

1.1

1.0

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

305

2.08

6.90

1.0

—

(3019832) Treponema pallidum Ab [Presence] in Serum

281

2027

1.41

6.79

1.4

1.6

—

(3044941) Cell count panel - Synovial fluid

110

644

1.73

6.76

1.7

1.4

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

146

921

1.60

6.75

1.6

1.9

11.84

11.99

mg/l

0.07

132

834

(3021901) Oxygen saturation in Capillary blood

134

830

1.63

6.67

3.0

3.3

—

(3011288) Drugs identified in Urine by Screen method

537

1.79

6.60

4.9

2.3

—

(3000060) B lymphocytes [#/volume] in Blood

122

2.72

6.59

3.5

2.6

132.08

311.49

e6/l

2.74

(3030313) Adrenal Ab [Titer] in Serum

5.73

6.58

1.5

1.0

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

173

1142

1.54

6.58

3.2

3.8

24.93

24.84

mmol/l

0.09

157

998

(3014891) Appearance of Pleural fluid

3.45

6.55

1.3

1.7

—

(3016038) Potassium [Moles/volume] in Urine

278

2.10

6.54

1.3

31.79

33.69

mmol/l

0.31

240

(3000330) Specific gravity of Urine by Test strip

296

2174

1.39

6.45

4.5

3.6

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

4.84

6.45

1.1

1.0

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

114

684

1.68

6.43

3.0

2.1

1963.59

3199.09

u/l

0.42

263

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

124

762

1.64

6.39

3.1

5.5

259.25

2571.12

iu/ml

—

112

(3043409) Potassium [Moles/volume] in Arterial blood

186

1258

1.50

6.32

3.7

3.8

3.86

3.91

mmol/l

0.78

178

1175

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

157

1029

1.54

6.19

1.5

1.6

0.17

9.24

iu/ml

0.94

237

(3023199) Leukocytes [#/volume] in Pleural fluid

579

1.73

6.15

1.4

1.5

2555.62

1883.64

e6/l

0.24

424

(3005322) IgE [Units/volume] in Serum or Plasma

277

2029

1.39

6.15

1.4

1.3

232.47

234.92

u/ml

0.02

255

1850

(3009343) pH of Capillary blood

382

2943

1.33

6.12

3.6

4.6

7.41

0.13

328

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

144

2180

0.65

6.09

1.7

1.8

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

3.09

6.03

1.2

1.3

—

(3000093) Morphology [Interpretation] in Blood Narrative

428

1.84

6.01

1.2

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1694

15292

1.17

6.00

4.8

5.4

4.43

3.96

ug/l

0.08

1508

13546

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

108

652

1.67

5.98

2.6

3.4

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

165

2.38

5.95

1.1

1.2

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

256

2.08

5.90

2.8

2.0

850.22

616.59

e6/l

1.20

(3021387) Prolactin [Units/volume] in Serum or Plasma

129

818

1.59

5.89

1.5

1.6

311.68

308.42

mu/l

0.04

115

750

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

384

2978

1.32

5.88

3.6

4.6

5.22

5.13

kpa

1.43

355

2755

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1372

12196

1.18

5.84

4.1

4.6

23.74

22.07

2.86

613

6441

(3044927) Protein electrophoresis panel - Urine

454

1.80

5.84

1.2

—

(40760892) CBC W Ordered Manual Differential panel - Blood

887

7593

1.21

5.77

4.7

4.6

—

(3025315) Body weight

4.65

5.73

3.7

4.6

—

(40768806) Pleura Pathology biopsy report

502

1.75

5.69

1.5

1.6

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

260

2.05

5.68

1.4

—

(3003327) Ova and parasites identified in Stool by Light microscopy

162

1091

1.50

5.66

1.7

—

(1002224) Polysomnography panel

159

1068

1.51

5.63

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

2.94

5.56

1.1

—

(3003434) Protein [Mass/volume] in Pleural fluid

107

658

1.64

5.55

1.4

1.5

32.60

31.56

g/l

0.33

596

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

368

2861

1.31

5.54

3.6

4.6

2.14

1.72

mmol/l

1.28

277

2086

(3013005) Retinol [Moles/volume] in Serum or Plasma

154

2.35

5.39

1.7

2.3

1.81

1.91

umol/l

0.27

146

(3023419) Bacteria identified in Sputum by Culture

518

1.71

5.39

2.2

2.7

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

336

1.89

5.34

1.1

—

u/ml

—

(40768443) Skin Pathology biopsy report

232

1693

1.39

5.31

1.3

1.2

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1081

9485

1.18

5.30

5.0

3.5

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.86

5.25

1.0

1.1

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1435

0.61

5.21

1.4

1.5

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

235

2.05

5.20

1.7

1.6

6.86

6.37

u/l

0.07

110

(3028308) Erythrocytes [#/volume] in Pleural fluid

532

1.69

5.17

1.4

153513.18

57539.76

e6/l

0.61

317

(3022493) Free Hemoglobin [Mass/volume] in Plasma

179

2.19

4.99

1.7

3.3

79.00

73.04

mg/l

0.11

129

(3021788) Differential panel - Synovial fluid

112

717

1.58

4.97

1.7

1.5

—

(3036782) Glucose [Moles/volume] in Pleural fluid

455

1.73

4.96

1.3

1.4

7.01

6.53

mmol/l

0.69

426

(3017704) Immunofixation for Urine

240

2.01

4.93

1.2

1.5

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

111

711

1.58

4.92

1.6

1.4

—

(3052592) Norovirus Ag [Presence] in Stool

2.78

4.87

1.6

1.4

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

143

2.32

4.83

2.5

2.1

63.17

51.89

umol/l

0.73

114

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

108

692

1.57

4.79

1.4

1.3

—

(3047181) Lactate [Moles/volume] in Blood

178

1268

1.42

4.72

5.8

6.3

1.32

1.31

mmol/l

0.07

154

1118

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

155

1081

1.45

4.61

1.4

1.7

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

612

1.60

4.60

3.5

1.8

—

(3035320) C reactive protein [Mass/volume] in Body fluid

289

1.88

4.59

3.0

2.3

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

114

748

1.54

4.57

2.8

3.7

57.99

57.80

0.05

114

748

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

101

645

1.58

4.56

1.4

1.3

265.44

265.38

u/ml

0.00

367

(3035637) Corticotropin [Mass/volume] in Plasma

475

1.67

4.54

1.2

1.6

—

(3036071) Salmonella sp Ab [Titer] in Serum

104

2.51

4.53

1.2

1.1

—

(3013336) Amino acids [Identifier] in Serum or Plasma

4.77

4.53

1.1

1.4

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

235

1766

1.35

4.52

5.7

5.2

1.77

1.62

1.21

215

1654

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

3.06

4.51

1.1

1.2

—

(40761535) Cells panel - Urine sediment

412

3349

1.25

4.39

3.8

3.6

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

330

1.80

4.38

1.5

1.6

18.11

22.35

u/ml

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

2.84

4.22

1.3

1.2

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

269

2091

1.30

4.12

4.3

3.5

25.44

25.10

mmol/l

0.89

260

2026

(3027456) Digoxin [Moles/volume] in Serum or Plasma

138

965

1.44

4.09

3.2

3.1

0.76

0.83

nmol/l

1.15

109

722

(3026692) Albumin [Mass/volume] in Peritoneal fluid

110

2.37

4.06

1.2

1.4

11.40

14.24

g/l

0.95

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

632

1.55

4.06

1.6

1.5

121.07

113.89

u/ml

0.29

121

(3007930) Methemoglobin/Hemoglobin.total in Blood

229

1747

1.33

4.02

5.8

5.2

0.87

0.88

0.24

210

1638

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

333

1.75

3.98

1.4

1.3

1.49

1.53

nmol/l

0.11

299

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

2.82

3.95

2.4

1.9

0.13

0.14

nmol/l

0.06

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

519

4376

1.21

3.92

2.7

4.1

11.33

24.20

ug/l

1.49

421

3597

(3032352) Blasts [#/volume] in Cerebral spinal fluid

3.43

3.90

1.0

3.2

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

2.89

3.89

12.4

13.3

3.99

5.76

mmol/l

3.56

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

4.17

3.88

1.1

1.3

11.80

11.42

u/l

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

498

1.60

3.83

1.1

1.53

g/l

0.01

442

(4062490)

330

1.74

3.81

1.4

1.3

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

153

2.10

3.77

1.3

1.7

1.68

6.92

nmol/l

1.16

130

(3000475) Leukocytes [#/volume] in Synovial fluid

137

973

1.42

3.77

1.7

1.6

14419.15

13425.72

e6/l

0.09

686

(3006922) Hepatitis E virus Ab [Presence] in Serum

223

1.89

3.72

1.1

—

(3016879) Cocaine [Presence] in Urine

108

735

1.48

3.72

3.4

1.9

—

(3025159) Blasts/100 leukocytes in Blood

353

2877

1.25

3.71

3.6

4.1

0.01

0.23

1.16

775

(3017181) Myelocytes/100 leukocytes in Blood

393

3241

1.23

3.70

3.6

4.0

1.12

0.94

0.30

108

988

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

141

2.14

3.70

1.3

1.4

3.31

3.99

umol/l

0.46

128

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

104

706

1.48

3.63

1.2

23.76

40.10

u/l

1.85

604

(3027135) IgG subclass 1 [Mass/volume] in Serum

329

1.71

3.58

1.4

1.3

6.35

6.93

g/l

0.53

239

(3024139) IgG subclass 3 [Mass/volume] in Serum

329

1.71

3.58

1.4

1.3

0.39

0.42

g/l

0.23

238

(3028192) IgG subclass 2 [Mass/volume] in Serum

329

1.71

3.58

1.4

1.3

2.26

2.91

g/l

1.85

239

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

7.79

3.55

1.1

1.2

788.40

374.94

nmol/l

—

(3039000) Anion gap in Blood

129

917

1.42

3.55

6.6

7.1

10.96

11.30

mmol/l

0.54

113

818

(3018572) Chloride [Moles/volume] in Blood

129

918

1.42

3.53

6.6

7.1

104.23

105.02

mmol/l

1.13

113

819

(3044009) aPTT.lupus sensitive (LA screen)

3.85

3.52

1.2

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

3.85

3.52

1.9

1.2

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

139

1007

1.39

3.44

1.4

1.3

—

(3047189) Immunofixation for 24 hour Urine

215

1.87

3.44

1.4

1.7

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

450

1.59

3.40

1.0

1.1

—

(3037121) Protein [Mass/volume] in Urine

190

1451

1.32

3.36

2.4

3.4

0.30

0.31

g/l

0.07

640

(3000764) Benzodiazepines [Presence] in Urine

112

786

1.44

3.33

3.3

1.8

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

142

2.05

3.25

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

272

1.74

3.20

1.4

1.2

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

215

1.82

3.13

1.1

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

215

1.82

3.13

1.1

1.0

—

(3044007) Cell count panel - Peritoneal fluid

111

2.17

3.12

3.3

1.8

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

437

1.56

3.11

1.1

1.5

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

2.29

3.09

1.1

1.0

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

105

2.20

3.08

1.3

1.2

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

159

1.96

3.08

1.3

—

(3021440) Promyelocytes/100 leukocytes in Blood

369

3086

1.21

3.07

3.5

4.0

0.13

0.08

924

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

231

1.78

3.07

1.4

1.3

—

(3027008) Opiates [Presence] in Urine

111

791

1.41

3.06

3.3

1.8

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

331

2743

1.22

3.02

2.2

2.1

11.72

12.04

nmol/l

0.25

255

2361

(40761539) Cells [Type] in Urine sediment by Light microscopy

106

2.18

3.02

1.1

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.89

3.02

1.0

1.2

—

(3002179) Metamyelocytes/100 leukocytes in Blood

351

2929

1.21

2.99

3.4

3.8

0.97

0.64

0.86

715

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

538

1.50

2.99

1.2

1.1

—

(4198724)

100

2.21

2.99

1.8

1.7

—

(3028300) Cannabinoids [Presence] in Urine

111

795

1.41

2.99

3.3

1.8

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

215

1701

1.28

2.96

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.83

2.91

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

115

2.09

2.88

1.8

1.7

—

(3049233) Organic acids panel - Urine

5.39

2.87

1.1

1.3

—

(3013637) Mi-2 Ab [Presence] in Serum

2.25

2.86

1.1

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.25

2.86

1.1

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.25

2.86

1.1

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.25

2.86

1.1

1.0

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

119

870

1.38

2.85

1.1

46.22

8.11

u/ml

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

892

0.65

2.82

4.9

3.6

26.01

28.66

mg/l

0.25

572

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

190

2401

0.78

2.80

1.4

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

489

1.50

2.80

2.1

1.7

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

135

1014

1.34

2.74

2.4

2.3

110.39

103.64

ug/min

0.08

598

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

160

1.88

2.70

1.3

1.4

1.29

1.46

g/l

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

175

1.83

2.67

1.8

1.5

15.45

22.74

umol/l

1.29

167

(3019174) dRVVT (LA screen)

3.60

2.57

1.2

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.73

2.54

1.3

1.0

—

(4024509)

413

1.51

2.48

1.7

1.6

—

(3004451) EKG impression Narrative

202

1.74

2.48

1.3

—

(3042733) HLA Ab [Presence] in Serum

102

2.06

2.46

5.8

4.3

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

282

2358

1.21

2.41

2.0

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.29

2.41

1.3

1.1

—

(3027944) Amphetamines [Presence] in Urine

105

777

1.36

2.39

2.2

1.8

—

(3023383) Lactate [Moles/volume] in Pleural fluid

147

1.84

2.32

1.0

1.3

4.03

3.32

mmol/l

0.46

134

(21494814) CD8 cells/100 lymphocytes in Specimen

126

1.91

2.30

1.7

2.0

—

(3022313) Gas panel - Capillary blood

261

2180

1.21

2.27

3.6

4.9

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

2.46

2.27

1.0

1.2

6.65

591118.15

nmol/l

—

(3005011) Chlamydia sp Ab [Titer] in Serum

2.46

2.27

1.7

1.5

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

3.48

2.27

2.5

1.3

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

700

1.36

2.24

1.2

1.4

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

399

1.48

2.23

2.3

2.9

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

5.56

2.21

1.0

1.2

—

(3026389) Candida sp identified in Specimen by Organism specific culture

467

1.44

2.18

1.5

1.4

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

410

1.47

2.16

1.1

4.44

3.38

u/ml

0.15

152

(3002331) Protein [Mass/volume] in Peritoneal fluid

2.07

2.16

1.6

1.4

21.41

27.32

g/l

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

211

1.66

2.16

3.5

4.2

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

4.29

2.15

1.0

1.2

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

3.69

2.15

1.4

1.2

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

204

1.67

2.13

2.3

2.5

42.50

37.78

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

259

1.59

2.11

1.7

1.9

—

(3035880) pH of Pleural fluid

275

1.57

2.11

1.1

1.3

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

228

1.63

2.11

1.3

1.4

0.46

1.42

u/ml

0.92

115

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

205

1.66

2.10

2.2

2.4

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

332

1.51

2.08

1.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

255

2146

1.20

2.08

1.9

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

5.00

2.07

1.0

1.5

253.60

432.10

nmol/l

—

(3040893) Potassium [Moles/volume] in Capillary blood

3.50

2.05

3.7

4.0

3.97

4.49

mmol/l

—

(40768441) Liver Pathology biopsy report

262

1.57

2.03

1.5

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

116

896

1.30

2.03

1.3

1.2

—

(3033799) Differential panel - Peritoneal fluid

125

1.84

2.02

2.0

1.8

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

278

2366

1.19

2.01

1.2

—

(3040151) Glucose [Moles/volume] in Capillary blood

503

1.40

1.96

4.4

7.9

6.85

7.53

mmol/l

1.23

423

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

164

1.71

1.94

1.0

1.3

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

102

780

1.31

1.93

2.0

1.7

0.86

0.79

nmol/l

0.39

647

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.96

1.89

1.3

1.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

136

1084

1.26

1.88

1.5

1.4

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

568

1.36

1.86

3.2

2.4

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

2.39

1.85

1.2

1.5

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

459

1.40

1.83

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

318

1.48

1.83

1.6

1.5

0.30

0.28

nmol/l

0.11

245

(3020393) Adenovirus Ag [Presence] in Stool

2.06

1.80

1.2

1.7

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

3.05

1.80

1.1

1.4

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.76

1.79

1.0

1.1

—

(3020491) Glucose [Moles/volume] in Blood

287

1.50

1.79

2.3

6.89

6.74

mmol/l

0.20

193

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

247

1.54

1.78

1.3

13.58

12.23

mmol/l

0.83

(3038177) Helicobacter pylori Ab [Presence] in Serum

505

1.37

1.76

1.4

1.3

—

(3025130) Human papilloma virus identified in Specimen

288

1.50

1.76

2.0

1.8

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

228

1935

1.19

1.74

3.8

5.0

25.06

24.64

mmol/l

1.27

209

1790

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

2.67

1.72

2.0

1.4

4.91

1.65

mg/l

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

2.67

1.72

2.0

1.4

3.46

1.29

mg/l

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

2.92

1.72

1.1

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

2.92

1.72

1.0

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.92

1.72

2.0

2.8

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

1.88

1.70

1.3

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

118

1.78

1.70

1.5

1.2

—

(3035285) Chloride [Moles/volume] in Venous blood

578

1.34

1.69

3.2

2.4

105.91

105.65

mmol/l

0.20

570

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

100

779

1.29

1.69

1.8

4.71

4.54

iu/l

0.06

242

(3041354) Potassium [Moles/volume] in Venous blood

579

1.34

1.67

3.2

2.4

4.12

4.10

mmol/l

0.18

571

(3042631) Mycobacterium sp identified in Specimen

573

1.33

1.63

2.6

2.9

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

105

1.81

1.62

1.8

2.0

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

120

1.75

1.62

3.3

1.9

1803.00

20957.92

e6/l

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

403

1.39

1.61

1.1

1.6

—

(3010375) cycloSPORINE [Mass/volume] in Blood

174

1.61

1.60

25.5

27.5

109.13

123.88

ug/l

0.68

149

(3002523) Influenza virus A Ag [Presence] in Specimen

413

1.38

1.58

1.1

—

(3014271) Vancomycin [Susceptibility]

247

1.50

1.57

3.5

3.0

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

1.82

1.57

2.6

2.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.20

1.56

1.0

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.11

1.55

1.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

289

1.46

1.54

1.7

2.8

10.54

11.49

umol/l

0.11

207

(3016750) Collection duration of Urine

240

1.50

1.54

2.0

505.05

489.68

min

0.39

172

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

1.93

1.54

1.1

1.4

121.33

106.03

0.98

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.28

1.53

1.3

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.28

1.53

1.3

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.28

1.53

1.3

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

789

0.74

1.47

1.4

1.5

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.22

1.46

1.1

—

(3036670) Protein [Mass/volume] in Synovial fluid

132

1.67

1.45

1.2

40.32

40.00

g/l

0.04

(3045716) Anion gap in Serum or Plasma

187

1.55

1.45

2.4

2.2

8.66

9.29

mmol/l

0.35

140

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

3.13

1.44

3.4

7.7

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

151

0.46

1.43

1.1

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

110

1.73

1.42

1.3

1.2

87.00

82.80

—

(44806420)

154

0.45

1.42

1.9

2.4

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

436

0.66

1.42

1.4

1.5

—

(3003740) Influenza virus B Ag [Presence] in Specimen

414

1.36

1.40

1.1

—

(4094501)

120

981

1.23

1.40

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

271

1.44

1.39

1.3

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

111

1.71

1.38

1.3

1.4

84.67

79.47

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.00

1.38

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.20

1.37

1.3

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

273

1.43

1.34

2.1

1.2

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

148

1242

1.20

1.34

1.8

1.9

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.00

1.34

0.0

1.0

—

162.89

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

566

1.29

1.34

1.5

1.6

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

496

1.31

1.34

1.4

1.6

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

384

1.36

1.33

1.2

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

626

0.73

1.31

1.7

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

559

1.29

1.31

1.3

1.4

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

547

5028

1.10

1.30

1.5

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.10

1.30

1.0

1.4

—

(3008898) HLA-B27 [Presence]

113

927

1.22

1.30

1.1

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

106

864

1.23

1.29

1.4

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

137

1.61

1.29

3.2

2.1

285.33

6168.26

e6/l

0.60

105

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

276

1.42

1.28

1.3

1.4

—

(3012898) Urea [Moles/volume] in Urine

2.29

1.26

1.1

1.2

207.88

149.23

mmol/l

—

(3028433) Virus identified in Specimen by Culture

130

1.62

1.26

1.1

1.2

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

751

1.24

1.25

1.4

1.6

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

398

0.68

1.23

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

398

0.68

1.23

1.4

—

(3017569) Oxygen content in Arterial blood

212

1.47

1.22

3.6

2.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

780

1.24

1.22

1.3

1.5

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

397

0.68

1.21

1.4

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.72

1.21

1.6

1.2

—

(3004616) Nuclear Ab [Presence] in Serum

426

1.32

1.20

1.3

1.2

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

117

1.63

1.18

1.2

1.5

—

(3005570) Glucose [Moles/volume] in Urine

367

1.34

1.17

2.0

1.9

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

368

1.34

1.15

1.1

—

2.58

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

309

1.36

1.13

1.2

1.3

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

208

1.45

1.12

1.4

1.3

—

(44813793)

225

1.43

1.12

1.1

1.0

—

(4015189)

115

0.43

1.11

3.2

2.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

372

4079

0.90

1.10

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

399

0.70

1.09

1.4

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

2.38

1.09

14.4

6.2

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.95

1.08

1.1

1.8

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

210

1.43

1.08

1.4

1.3

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

373

1.32

1.07

1.2

1.4

30773.33

93834.66

e6/l

1.18

262

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

350

1.32

1.02

1.5

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

291

1.34

0.99

3.4

5.0

230.04

67.50

u/ml

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

240

1.38

0.98

1.2

1.5

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

2.18

0.98

3.4

2.9

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

2.18

0.98

3.6

5.0

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

2.18

0.98

3.6

5.0

—

(3032773) Endomysium IgG Ab [Titer] in Serum

318

1.32

0.97

1.1

—

(3024263) Appearance of Synovial fluid

232

1.38

0.97

1.3

1.7

—

(4281824)

373

1.29

0.93

1.1

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

553

1.23

0.92

1.3

1.4

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

1.67

0.91

1.8

2.8

2.70

1.81

mmol/l

—

(3019977) pH of Arterial blood

235

1.36

0.91

3.4

2.5

7.43

7.42

0.28

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

407

0.74

0.91

1.5

1.3

7.48

7.58

mmol/l

0.06

285

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

709

0.80

0.91

1.5

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

2.07

0.89

1.0

1.3

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

2.07

0.89

1.2

1.1

—

(3045142) Bone marrow Pathology biopsy report

502

1.24

0.88

1.2

1.3

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

111

1.53

0.87

1.2

1.3

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

323

0.71

0.87

1.4

1.5

—

(3050129) First trimester maternal screen panel - Serum or Plasma

504

0.77

0.86

1.3

1.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

239

1.34

0.84

1.3

1.5

—

(21494434) Karyotype in Bone marrow

398

1.26

0.83

1.1

1.2

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

443

1.24

0.83

1.3

1.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

116

1004

1.16

0.82

1.5

1.8

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.88

0.81

1.2

1.1

—

(3004775) Volume in Urine collected for unspecified duration

346

1.27

0.81

2.0

2.2

678.96

621.77

0.36

215

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

113

980

1.16

0.79

1.3

1.6

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.82

0.79

1.0

1.2

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

592

1.20

0.78

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

366

1.26

0.78

1.2

1.3

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

366

1.26

0.78

1.3

1.5

20.34

26.59

0.63

228

(3005033) Fetal Nuchal fold Thickness US

315

0.73

0.77

1.4

—

(40765096) Chromosome analysis panel by Banding

126

0.55

0.77

1.0

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.77

0.76

1.0

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

314

1.28

0.76

1.5

1.4

30.45

25.66

u/l

0.42

259

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.70

0.75

1.1

1.4

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.70

0.75

2.0

2.1

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

116

1013

1.15

0.75

1.3

1.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

220

0.68

0.74

1.5

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

220

0.68

0.74

1.5

1.4

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

201

1.35

0.74

1.9

1.4

1.03

1.16

nmol/l

0.34

154

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

381

3552

1.08

0.73

1.6

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

210

1.34

0.73

1.9

1.6

2.38

3.19

u/field

0.35

153

(3015183) Erythrocyte sedimentation rate

132

0.61

0.73

1.0

1.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

325

1.26

0.73

2.4

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

334

0.75

0.72

2.0

1.6

—

(3035933) Granulocytes/100 leukocytes in Blood

106

0.57

0.72

1.0

1.6

—

(4146454)

489

0.80

0.71

2.8

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.58

0.71

2.0

—

(3013293) Extractable nuclear Ab [Presence] in Serum

1.71

0.70

1.6

1.5

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

221

1.31

0.69

1.1

12.70

10.74

iu/ml

—

(40768800) Prostate Pathology biopsy report

1039

0.86

0.69

1.2

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.85

0.68

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

1.85

0.68

1.0

—

(3024932) HLA-DR beta [Type]

110

1.46

0.68

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

317

0.76

0.66

1.4

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

595

1.18

0.66

1.4

1.5

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.79

0.66

1.8

6.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.54

0.65

1.2

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

313

1.25

0.64

1.2

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.63

0.62

1.0

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

1.67

0.61

1.8

5.8

33.80

20.07

mg/l

—

(3024471) HLA-A [Type]

113

1.42

0.61

1.0

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.48

0.60

1.3

1.4

10.88

9.29

ug/l

0.59

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

621

1.16

0.59

1.3

1.4

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.00

0.58

0.0

1.4

—

341.04

—

(3050794) Legionella sp Ab [Presence] in Serum

1.72

0.57

1.2

1.1

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

312

1.22

0.54

1.5

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

372

0.81

0.53

1.5

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

176

1617

1.09

0.53

2.0

1.8

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

169

1.30

0.53

1.0

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.45

0.53

1.1

1.3

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

470

1.17

0.52

1.4

1.5

70.39

60.99

1.07

297

(1617658) Protocol used for examination of sentinel lymph nodes

260

0.77

0.52

1.1

1.0

—

(3006270) Folate [Moles/volume] in Blood

369

1.19

0.51

1.2

363.97

338.03

nmol/l

0.35

294

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.41

0.51

2.2

1.6

164.56

148.21

ng/l

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

1.47

0.50

2.3

3.2

70.67

110.09

ng/l

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.49

0.49

4.5

7.1

—

(3013512) EKG study

1204

11728

1.04

0.49

4.8

4.3

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

1.56

0.49

1.7

1.9

6.81

3.57

nmol/l

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.40

0.48

1.2

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

137

1.32

0.47

1.1

1.3

—

(40757373) Influenza virus identified in Isolate

1.41

0.46

1.2

1.5

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

782

0.88

0.46

1.3

1.4

—

(4212803)

1.43

0.46

1.0

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

287

0.80

0.45

1.4

1.5

—

(3011544) Albumin [Mass/volume] in Pleural fluid

1.40

0.45

1.1

15.47

17.53

g/l

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

165

1.27

0.45

1.2

1.13

1.06

ratio

0.70

(3025018) Bordetella pertussis Ab [Titer] in Serum

201

1.25

0.44

1.3

1.2

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.37

0.44

1.4

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.61

0.43

1.0

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

185

0.76

0.43

1.0

1.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

530

0.87

0.41

1.3

1.4

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

1.34

0.38

1.1

2.4

—

(3020650) Glucose [Presence] in Urine

0.66

0.35

1.8

1.6

—

(40768793) Breast Pathology biopsy report

736

1.10

0.35

1.3

—

(3044242) Glucose [Moles/volume] in Arterial blood

217

1.20

0.35

3.3

1.9

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.32

0.33

5.6

7.8

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.32

0.33

1.5

1.3

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

293

1.16

0.33

2.0

1.7

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

188

0.80

0.33

1.1

28.07

33.37

u/l

—

142

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

187

0.80

0.32

1.1

83.98

89.05

u/l

—

144

(3012494) Peanut IgE Ab [Units/volume] in Serum

119

1.26

0.31

1.1

1.2

0.57

3.02

u/ml

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.35

0.31

1.6

1.8

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

527

0.89

0.31

1.3

1.4

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.32

0.30

1.0

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

704

0.91

0.30

1.2

1.3

308.50

216.90

miu/ml

0.92

292

(3004809) Band form neutrophils/100 leukocytes in Blood

706

1.09

0.30

3.0

3.6

1.28

1.53

0.27

544

(3025468) Yersinia sp identified in Specimen by Organism specific culture

525

0.89

0.29

1.3

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

525

0.89

0.29

1.3

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

525

0.89

0.29

1.3

1.4

—

(40758292) HTLV I+II Ab panel - Serum

1.23

0.29

1.1

1.3

—

(3000285) Sodium [Moles/volume] in Blood

1.23

0.29

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

176

1.19

0.28

1.3

1.2

5.20

3.06

u/ml

0.17

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

103

1.26

0.28

5.3

7.6

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

1.29

0.28

2.2

2.6

—

(3026470) Cobalt [Mass/volume] in Blood

290

0.86

0.27

1.9

3.62

3.59

ug/l

0.01

247

(3000012) Reticulocyte production index

243

1.15

0.26

1.1

1.5

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

171

0.82

0.26

1.2

1.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

0.68

0.26

1.2

1.0

—

(3003129) Base excess in Capillary blood by calculation

114

1.23

0.25

1.7

1.9

1.50

0.88

mmol/l

0.22

104

(3017732) Neutrophils [#/volume] in Blood

259

2492

1.04

0.25

2.7

3.2

4.40

4.19

e9/l

0.49

195

1837

(40768446) Kidney Pathology biopsy report

151

1.19

0.25

1.9

1.7

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.18

0.24

1.1

1.3

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

142

1.20

0.24

1.2

1.3

150.56

552.92

ug/l

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

1.25

0.24

1.0

1.2

2.26

1.63

mmol/l

—

(44790048)

465

1.10

0.24

1.2

1.5

—

(44790049)

465

1.10

0.24

1.2

1.5

—

(44790047)

465

1.10

0.24

1.2

1.5

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

296

0.88

0.23

1.2

1.1

0.09

0.36

u/ml

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.25

0.22

3.4

2.0

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.25

0.22

3.2

2.2

1.00

0.57

u/field

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

210

0.86

0.22

1.2

1.5

145.44

185.65

pmol/l

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

296

1.12

0.21

1.1

40.20

60.74

u/ml

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

0.20

0.0

1.0

—

(3013762) Body weight Measured

0.00

0.20

0.0

1.3

—

(40768795) Lymph node Pathology biopsy report

365

0.90

0.19

1.2

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

1.21

0.19

1.2

1.3

28.86

29.88

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

183

1761

1.04

0.19

2.1

1.9

—

(3051101) Glucose [Moles/volume] in Cord blood

1.24

0.18

2.9

6.8

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

351

0.91

0.17

1.1

12.06

4.85

u/ml

0.43

148

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

537

0.93

0.17

1.3

1.4

—

(44806118)

465

1.08

0.17

1.2

1.5

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

0.75

0.17

1.0

1.3

16.52

36.13

nmol/l

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

167

1.14

0.16

1.2

1.7

—

(3041806) Other cells [#/volume] in Blood by Manual count

1.14

0.16

1.4

1.6

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.11

0.16

1.1

1.3

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

197

1.12

0.15

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.14

0.15

1.0

1.5

—

(3048879) Bone marrow aspiration report

129

0.85

0.14

1.0

1.5

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

294

1.09

0.14

1.1

66.83

71.88

u/ml

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

150

0.87

0.14

2.6

2.5

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.80

0.14

1.6

1.5

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

1.18

0.14

1.3

2.4

5.67

7.88

mmol/l

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

440

1.07

0.14

3.5

3.4

62.60

58.14

0.66

278

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

285

1.09

0.14

1.4

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

501

0.94

0.14

1.1

1.51

1.64

u/ml

0.07

246

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

122

1.15

0.13

1.4

1.6

9.00

7.75

mmol/l

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

344

1.08

0.13

2.1

2.2

2.18

1.84

u/field

0.10

129

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

108

0.83

0.13

1.4

2.0

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

161

1.12

0.13

6.3

5.0

9353.60

62.07

u/ml

—

(3032057) Clostridioides difficile [Presence] in Stool

104

1.15

0.12

1.3

1.8

—

(3037556) Urate [Mass/volume] in Serum or Plasma

124

1.13

0.11

1.7

1.5

—

(3022689) Creatine [Moles/volume] in Urine

105

1.14

0.11

1.2

1.6

—

(3043410) Blood group antigens tested for on Red Blood Cells

115

1.13

0.10

1.5

1.9

—

(4034850)

114

1175

0.97

0.10

8.4

10.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

114

1175

0.97

0.10

1.7

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.15

0.10

1.3

1.2

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

161

1571

1.03

0.10

3.1

3.8

52.06

67.11

u/ml

0.40

153

1513

(4211845)

212

1.09

0.10

5.0

3.6

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

100

1032

0.97

0.10

1.4

1.6

3.19

3.62

mg/l

0.25

732

(3019225) pH of Specimen

407

4125

0.99

0.09

4.2

4.6

—

(3009871) Measles virus Ab [Titer] in Serum

1.15

0.09

1.8

1.7

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

291

1.07

0.09

1.4

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

165

1.09

0.08

1.2

1.7

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

165

1.09

0.08

1.2

1.7

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

548

1.04

0.08

2.8

2.2

51.55

22.80

mg/l

0.74

132

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

117

1.11

0.08

1.2

1.0

94.57

90.11

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.09

0.08

4.0

8.3

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.04

0.08

1.0

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.08

0.07

1.5

1.6

—

(3006462) Nitrate [Presence] in Urine

196

1.07

0.07

5.4

3.7

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

509

0.96

0.07

1.2

1.1

6.88

5.15

u/ml

0.21

283

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

118

1.10

0.07

1.3

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.05

0.07

1.0

1.1

—

(3051593) INR in Capillary blood by Coagulation assay

216

1.07

0.06

5.7

14.6

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

173

0.92

0.06

1.0

1.2

0.54

12.22

u/ml

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

501

4969

1.01

0.06

8.5

7.4

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

572

1.03

0.06

1.2

1.87

2.35

u/ml

0.12

258

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

100

1.10

0.05

2.2

2.3

—

(1761482) Bacteria [#/volume] in Urine by Culture

115

1168

0.98

0.04

7.0

4.3

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

281

0.96

0.04

1.1

1.3

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

351

0.97

0.03

1.3

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

351

0.97

0.03

1.3

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

351

0.97

0.03

1.3

1.5

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

320

0.97

0.03

1.1

4.90

5.73

u/ml

0.15

139

(3000034) Microalbumin [Mass/volume] in Urine

380

0.97

0.02

2.9

3.2

203.46

29.75

mg/l

0.53

293

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

100

989

1.01

0.02

1.8

1.7

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

456

0.99

0.00

1.1

3.12

3.07

u/ml

—

120

(3045424) Erythrocytes [Presence] in Urine

656

0.99

0.00

1.5

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

108

1.02

0.00

1.2

1.4

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

122

0.98

0.00

1.9

2.2

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

122

0.98

0.00

1.9

2.2

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1.05

0.00

5.6

1.5

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

222

0.99

0.00

2.1

3.5

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

195

1.03

0.00

5.4

6.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

205

1.02

0.00

1.2

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

205

1.02

0.00

1.2

1.6

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

205

1.02

0.00

1.2

1.6

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

205

1.02

0.00

1.2

1.6

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

487

1.01

0.00

3.0

4.2

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3034614) HLA Ag [Interpretation]

0.00

0.0

1.2

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.0

9.0

—

(3006598) pH of Arterial cord blood

0.95

0.00

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.0

1.2

—

1902.00

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

40.60

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.4

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3038702) Sodium [Moles/volume] in Capillary blood

0.00

0.0

7.2

—

137.20

—

(3026820) Hemoglobin [Mass/volume] in Venous cord blood

0.00

0.0

1.0

—

165.75

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

0.00

0.0

1.0

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.89

0.00

1.0

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

0.98

0.00

1.2

8.72

7.08

mg/l

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

0.95

0.00

2.8

2.5

10.36

9.26

mg/l

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

0.95

0.00

1.1

1.2

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

0.0

1.4

—

1.85

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

0.00

0.0

1.0

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

160

1.00

0.00

1.4

1.3

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: R18_ABNORMALITI_GAIT_MOBIL – Abnormalities of gait and mobility

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Abnormalities of gait and mobility

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Abnormalities of gait and mobility (R18_ABNORMALITI_GAIT_MOBIL)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints